SlideShare a Scribd company logo
1 of 8
Download to read offline
IMMUNOLOGY                    REVIEW ARTICLE


Endosomal processing for antigen presentation mediated by CD1
and Class I major histocompatibility complex: roads to display or
destruction

Marianne Boes,1,2 Arie J.                        Summary
Stoppelenburg1 and
                                                 The presentation of antigen in a form that can be recognized by T lym-
Fenna C. M. Sille2
                ´
1
                                                 phocytes of the immune system requires antigen processing and associa-
 Department of Pediatric Immunology, Univer-
                                                 tion of antigen-derived fragments with molecules encoded by the major
sity Medical Center Utrecht, Wilhelmina
Children’s Hospital, Utrecht, the Netherlands,   histocompatibility complex (MHC) locus or by the CD1 locus. Much
and 2Department of Dermatology, Brigham          emphasis on antigen processing and presentation in the last decades has
and Women’s Hospital and Harvard Medical         focused on what we consider ‘conventional routes’ of antigen processing
School, Boston, MA, USA                          and presentation, whereby extracellular antigens are processed for presen-
                                                 tation via Class II MHC complexes and cytosolic antigens are presented
                                                 as peptide–Class I MHC complexes. We here highlight two other path-
                                                 ways in myeloid dendritic cells, those of lipid antigen presentation in
                                                 association with CD1 and of peptide cross-presentation via Class I MHC
                                                 complexes. Some pathogens evade immune recognition through inhibition
doi:10.1111/j.1365-2567.2009.03078.x             of antigen presentation of phagosomal origin. Deviations in endosomal
Received 14 November 2008; revised 15            antigen processing and presentation are also seen in individuals suffering
January 2009, 2 February 2009; accepted 4
                                                 from glycosphingolipid lysosomal lipid storage diseases. We summarize
February 2009.
Correspondence: M. Boes, Department of           recent developments in the endosomal antigen processing and presenta-
Pediatric Immunology, University Medical         tion pathway, for display as lipid–CD1 complexes to natural killer T cells
Center Utrecht, Wilhelmina Children’s            and as peptide–Class I MHC complexes to CD8 T cells.
Hospital, Utrecht, the Netherlands.
Email: mboes@umcutrecht.nl                       Keywords: CD1d; cross-presentation; endosome; major histocompatibility
Senior author: Marianne Boes                     complex Class I; myeloid dendritic cell




                                                                    chain [of approximately 43 000–49 000 molecular weight
Introduction
                                                                    (MW)]       that    assembles    with     b2-microglobulin
The initiation of strong adaptive immune responses that             (12 000 MW) and endogenous peptide or lipid in the
yield memory requires the processing and presentation of            endoplasmic reticulum, respectively. Exogenous antigens
antigen as peptide–major histocompatibility complex                 provide alternative sources of peptides for Class I MHC,
(MHC) complexes or as lipid–CD1 complexes to T lym-                 for loading in phagosomes.5 The number of CD1 iso-
phocytes.1 Class I MHC is expressed on most nucleated               forms expressed varies among species: humans express
cells, whereas CD1 expression and Class II MHC expres-              several antigen-presenting isoforms of CD1 – CD1a,
sion are more restricted, being constitutive on profes-             CD1b, CD1c and CD1d – that complement one another
sional antigen-presenting cells (APCs) [i.e. on dendritic           in the sampling of antigen from various endosomal com-
cells (DCs), B cells and macrophages]. Thymic selection             partments,6 whereas mice only express the CD1d iso-
of MHC-restricted T lymphocytes occurs by presentation              form.7 Humans additionally express CD1e, which during
of peptide–MHC complexes on thymic stroma cells, while              DC maturation translocates from the Golgi to lysosomes,
selection of CD1-restricted natural killer T cells (NKT             where CD1e is thought to facilitate the selection of anti-
cells) occurs on CD1-expressing cortical thymocytes, as             genic lipids for surface display via other members of the
shown in mice.23 MHC-restricted T cells require clonal              CD1 family.8
expansion to execute key roles in adaptive immune                     Much of what is known to date about CD1-mediated
responses, whereas CD1-restricted NKT cells act within              antigen presentation and T-cell selection is obtained from
hours of stimulation by secreting polarizing cytokines.4            mouse-based experiments. Semi-invariant NKT cells rep-
Class I MHC and CD1 molecules both contain one heavy                resent approximately 80% of all CD1d-restricted T cells


Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170                                                                 163
M. Boes et al.

in mice and express a T-cell receptor (TCR) that contains       ing of pathogen-recognition receptors often coincides
a Va14-Ja18 assembled with Vb8, Vb7 and Vb2-contain-            with the ligation of receptors to inflammatory cytokines,
ing TCR b chains.9 Antigens recognized by semi-invariant        for example interferon-c (IFN-c) and tumour necrosis
NKT cells are derived from lipid membranes in endo-             factor-a (TNF-a), on DCs. Signals integrated from these
somes and lysosomes from foreign or host origin.9 As can        receptors instigate in DCs the rearrangement of the anti-
be expected from the cargo loaded into the antigen-bind-        gen processing and presentation machinery in endosomes
ing grooves, the hydrophobic CD1d-binding groove                for induced cell-surface display of antigenic peptide–
contains two large cavities that facilitate the binding of      MHC and lipid–CD1 complexes.
non-polar alkyl chains and exposes the polar glycolipid
headgroup,10 whereas MHC molecules harbour a groove
                                                                Pathogen recognition receptors as modulators of
that is lined with charged residues to facilitate the binding
                                                                endosomal antigen processing
of peptide anchor residues.11,12 Some peptides can bind
CD1 and these are overall hydrophobic in character. The         Ligation of receptors specific for pathogen-associated
MHC locus is polygenic (> 200 genes in human) and               molecular patterns (PAMPs) expressed by DCs deliver sig-
exceptionally polymorphic, whereas CD1 gene products            nals that can stimulate the differentiation of DCs from
are monogenic or have a very limited range of alleles. The      being primarily phagocytic sentinels into potent APCs
single CD1d protein that is expressed in mice, however,         capable of T-cell stimulation. These receptors are collec-
can adopt different conformations that facilitate the bind-     tively called pattern recognition receptors (PRRs) and
ing of related ceramides from endogenous and acquired           include three major families: Toll-like receptors (TLRs);
sources (i.e. iGb3 and alpha-Galactosyl ceramide),10            intracytoplasmic nucleotide oligomerization domain
thereby allowing the presentation of multiple antigens.         (NOD)-like receptors; and cell-surface C-type lectin recep-
One can imagine that other CD1 isoforms may take on             tors. DCs can also be activated indirectly by capture of frag-
multiple conformations as mouse CD1d does: human                ments of cells that died in response to infection or tissue
CD1b can present glucose monomycolates that vary sig-           injury. DCs express selected sets of PRRs belonging to these
nificantly in their lipid tail fine structures and overall        receptor families, the composition of which helps focus the
lengths,13 a capability that may be attributable to confor-     type of adaptive response that can be raised by DC sub-
mational flexibility. Variability in CD1 conformations           types. Langerhans’ cells (LCs), for example, do not express
may therefore increase the antigen-presentation repertoire      TLR4 and TLR5, whereas dermal interstitial DCs do express
presented to CD1-restricted T-cell clones.                      TLR4 and TLR5.16 There is, furthermore, integration of sig-
   T-cell stimulation requires instructive signals that sup-    nals downstream of PRRs: the simultaneous ligation of
plement signals incited by triggering of the TCR. DCs in        TLRs 3, 4 and 8 yields a 20–50-fold increase in interleukin
particular are proficient at T-cell stimulation to mount         (IL)-12 p70 production compared with the single ligation
the adaptive immune responses most appropriate for the          of either TLR;17,18 and TLR4 is located at the cell surface,
pathogen at hand. DCs can rapidly and effectively form          whereas TLRs 3 and 8 are found intracellularly, in endoso-
peptide–MHC complexes or lipid–CD1 complexes derived            mal compartments, thereby illuminating the fact that signal
from encountered pathogens, and rapidly up-regulate the         integration occurs distal from TLR cytosolic domains. Use
surface expression of costimulatory molecules and chemo-        of divergent sets of adaptor molecules for signal transduc-
kine receptors.14 The possession of an elaborate endosomal      tion (i.e. TIRAP-MyD88 and TRAM-TRIF) can direct the
pathway, where antigens are degraded and loaded onto            TLR-induced production of selective pro-inflammatory
MHC or CD1, is likely to contribute to the success of           cytokines.19 Cytosolic triggering of PRRs, through ligation
DCs in stimulating antigen-specific T-cell responses. For-       of NOD-like receptors, can, moreover, activate a caspase-1-
eign-derived antigens are most readily acquired at barrier      activating multiprotein complex called inflammasome.20
surfaces with the outside environment; only when patho-         NACHT, LRR, and pyrin domain-containing proteins
gens succeed at breaching the physical and chemical bar-        (NALPs), which constitute the largest subfamily of the
riers of skin and mucosa are they exposed to cells of the       NOD-like receptors, process pro-inflammatory caspases
immune system. It is becoming increasingly clear that           and the cytokines IL-1b and IL-18 into their active forms.21
DCs form a network of cell types that have specialized          If combined triggering of PRRs potentiates DC activation,
characteristics: DCs found in barrier tissues acquire           what is the effect of the simultaneous ligation of multiple
mobility when pathogen-recognition receptors exposed on         TLRs on the antigen processing and endosomal transport
their plasma membrane are triggered, whereas other DC           of peptide–MHC or lipid–CD1 complexes?
subtypes found in secondary lymphoid tissues (i.e.                 The loading of Class II MHC and of CD1d with anti-
murine CD8a+ DCs) do not have significant migratory              genic cargo occurs in specializations of late endosomal
capacities but are instead optimized for antigen cross-pre-     and lysosomal compartments.22 Endosomal tubulation is
sentation.15 DCs also have a potent ability to process and      an early measure of DC maturation and is thought to
present antigenic lipids in association with CD1. Trigger-      facilitate the transport of peptide-loaded Class II MHC


164                                                                 Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170
Regulated presentation of endosome-derived antigens by myeloid dendritic cells

complexes to the cell surface.23,24 In maturing DCs, CD1                                                       Dendritic cell


molecules are not mobilized to endosomal tubules and do                                             Immature                Mature


not exhibit rapid surface display as seen for Class II
MHC.25,26 The loading of Class I MHC for cross-presenta-
tion can occur in early endosomes/phagosomes5,27 as well
as in the endoplasmic reticulum28 and perhaps also in a
hybrid form of these two combined.29,30 The assortment
of Class I MHC molecules that are found in early endoso-
mal compartments are recycling Class I MHC molecules
from the surface.31,32 The origin of Class I MHC
complexes that localize to the cell surface during DC
                                                                                                                                 Endosomal
maturation, however, is new synthesis rather than transfer                                                                       compartments

of existing Class I MHC present in endosomal/lysosomal
compartments33 and is therefore not expected to be
strongly represented in endosomal tubulations. The DC                                                                           Golgi system
                                                                             Class I MHC
maturation-associated disposition of Class I MHC, Class                      mCD1d
                                                                             Class II MHC                                             Endoplasmic chains
II MHC and mouse CD1d complexes in various subcellu-                                                                                  reticulum

lar compartments is summarized in Fig. 1. Antigen degra-
dation in endosomal compartments is also regulated in
                                                                   Class I MHC heavy chain with β2m and peptide                      Endosome with transporter associated with
DCs:34,35 DCs exhibit less lysosomal proteolysis than                                                                                antigen processing (TAP)

macrophages.36–38 In DCs, a low level production of                mCD1d heavy chain with β2m and glycolipid                         Putative mCD1d chaperone molecule

reactive oxygen species produced by NADPH oxidase                  Class II MHC α and β chain with partially                         Microbe
consumes protons in the phagosomal lumen, supporting a             cleaved invariant chain

near-neutral pH environment and favouring peptide                  H2-DM                                                             Antigenic glycolipid and peptide


retention for presentation to T cells. This delay in antigen
degradation apparently promotes antigen cross-presenta-         Figure 1. Intracellular distribution and trafficking of Class I major
tion via Class I MHC.38 Control of antigen degradation          histocompatibility complex (MHC), Class II MHC and mouse CD1d
may additionally involve regulation in spatially confined        (mCD1d) in maturing dendritic cells. Complexes are assembled in the
                                                                endoplasmic reticulum (ER). To allow them to fold into functional
antigen-containing compartments rather than regulation
                                                                complexes in the ER, chaperone molecules are co-assembled: antigenic
at a cellular level, for example by local ligation of PRRs.39
                                                                peptide–Class I MHC; invariant chain–Class II MHC; and endogenous
TLRs can be triggered inside endosomal compartments by          lipid–CD1d (i.e. phosphatidylinositol and glycosyl-phosphatidylinosi-
phagocytosed microbes.40 Triggering of PRRs can induce          tol).96,97 After arrival at the cell surface by routing through the
maturation of selective PAMP-containing phagosomes and          secretory pathway, Class I MHC display and CD1d molecules recycle
thereby promotes the generation of peptide–MHC                  through early endocytic compartments, from where CD1d molecules
complexes in PAMP-containing phagosomes.41 PRR trig-            are sorted to late endocytic/lysosomal compartments for exchange of
gering promotes CD1d-mediated lipid presentation.42–44 It       ER-derived lipid for antigenic lipid cargo. Most nascent invariant
is not clear, however, whether NADPH oxidase activity           chain–Class II MHC complexes arrive in the endosomal pathway
modulates the generation of lipid–CD1 complexes in DCs.         directly from the Golgi system for acquisition of antigenic peptide.
                                                                Chaperone proteins can facilitate antigen loading in the ER (Class I
                                                                loading complex for Class I MHC98 and some processes of CD1d
Pattern recognition receptors as modulators of                  assembly,99 and lipid transfer proteins for lipid loading)100 and in
endosomal composition                                           the endosomal pathway (H2-DM for Class II MHC101,102 and lipid
                                                                transfer proteins for mCD1d).92,95,103 Maturation of DCs rearranges
The ligation of TLRs induces the transcription of genes         intracellular trafficking to promote the presentation of newly acquired
that collectively facilitate the differentiation process in     antigen from ER or endosomes at the cell surface, for inspection by
DCs called maturation. The integration of TLR-induced           appropriately restricted T cells. Arrow thickness represents the relative
signals makes use of adaptor proteins, the most studied of      rate of translocation of Class I MHC, Class II MHC and mCD1d
which is MyD88, which is involved in signal transduction        complexes. b2m, beta-2-microglobulin.
downstream of TLRs 1, 2, 4, 5, 6, 7 and 9 in mice.45
MyD88-deficient APCs exhibit deficiencies in antigen
cross-presentation and are defective in eliciting functional    was suggested that the cross-presentation of soluble anti-
cytotoxic T lymphocytes (CTL) in vivo.46 Cross-presenta-        gens which contain PAMPs is especially dependent on the
tion of phagosomal antigens by myeloid DCs requires pro-        loading of Class I MHC in early endosomes/phagosomes:
cessing by the proteasome in most experimental systems,         antigen cross-presentation required TLR4/MyD88-medi-
thereby inferring the necessity to transfer protein frag-       ated signals for phagosomal recruitment of transporter
ments from the endosomal pathway into the cytosol.47 It         associated with antigen processing (TAP) heterodimers


Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170                                                                                                               165
M. Boes et al.

(TAP1/2).5 Triggering of TLR4 via treatment with lipo-       excluded from cross-presentation.63 Some receptors are
polysaccharide (LPS) also stimulates, in DCs, the rear-      more effective than others at targeting of antigen for
rangement of endosomal compartments to exhibit tubular       cross-presentation: Gram-negative bacteria (whose
structures.23,24,48,49 Class I MHC molecules are also con-   uptake by DCs is facilitated by binding to complement
centrated in multivesicular bodies (MVB) of the endoso-      receptor 3) are fully degraded, whereas peptide antigen
mal pathway,50 which represent the structures from which     expressed by bacteria internalized via binding to receptors
tubular endosomes are formed.48 MyD88-deficient DCs do        to the Fc portion of immunoglobulins (Fc-receptors) are
not form tubular endosomes when triggered with LPS, yet      effectively cross-presented.63 Recruitment of the Rab27a
do form tubular endosomes when triggered with                small GTPase to phagosomal membranes is involved in
Cryptococcus neoformans.51 C. neoformans can ligate TLR2     this antigen cross-presentation process in DCs, which also
in addition to TLR4, whose signaling cascades both           includes NADPH oxidase recruitment.64 CD1-mediated
involve MyD88 as well as TIRAP and TRIF, respectively.45     antigen presentation of exogenous antigen also benefits
The ligation of TLR3 (which is expressed on the              from receptor-mediated uptake, for example via the
endosomal membranes of CD8a+ DCs) with double-               C-type lectins Langerin and DC-SIGN, mannose receptor
stranded RNA (dsRNA) present in the cell-associated          and low-density lipoprotein receptors (LDL-R),65–68
form of phagocytosed virus-infected cells promotes cross-    although details that link receptor-mediated uptake with
priming and induction of antigen-specific CTLs.52             endosomal processing of lipid antigens are scarce.68
Co-ligation of multiple TLRs also potentiates CTL            Uptake of apoptotic blebs (for example through binding
responses in vivo.53 What is known about endosomal           to b3 integrins or to CD14) can also introduce
mechanisms that link TLR ligation with endosomal             antigenic cargo to Class I MHC and CD1 molecules
remodeling and possibly with antigen presentation via        into uninfected bystander DCs, as was shown using
Class I MHC or CD1?                                          apoptotic macrophages that harbored Salmonella typhimu-
                                                             rium or Mycobacterium tuberculosis.69,70
                                                                Ceramides, lipids that are composed of a sphingosine
Endosomal sorting of Class I MHC and CD1 for
                                                             and fatty acid chain, are crucial for sorting lipids and
antigen acquisition
                                                             proteins into intravesicular membranes of exosomes and
DC maturation induced by TLR ligation stimulates new         MVBs.71 The endosomal-sorting mechanisms for peptide
synthesis of Class I MHC molecules and induces antigen       loading of Class II MHC in MVBs are relatively well
loading of small stores of phagosomal Class I MHC.5 A        established.22 In unstimulated cells, both glycosphingo-
fraction of the cellular content of Class I MHC is found     lipid (GSL) ligands and CD1d are also found in
in late endosomal compartments.50,54 Surface display of      MVBs.72 Microbial infection of susceptible hosts, how-
endosomal Class I MHC via exosome release, however, is       ever, rearranges the CD1-mediated antigen-presentation
down-regulated when DCs undergo maturation.55 Upon           pathway to accommodate the stimulatory effects of
exposure to inflammatory stimuli, Class II MHC mole-          CD1-restricted NKT-cell responses.43,44 Microbial infec-
cules acquire antigen in phagosomes/lysosomes, then          tions yield presentation of acquired lipids or mobilized
accumulate on the plasma membrane to display peptides        self-derived lipids by APCs. Infection with Ehrlichia
to CD4 T cells as part of DC maturation.56,57 Matura-        muris and Sphingomonas capsulata, for example, causes
tion-induced relocation of antigen-loaded Class I MHC        CD1d-mediated NKT-cell activation primarily through
and CD1 from the endosomal pathway to the cell surface       direct recognition of microbial lipids.43 By contrast,
is relatively modest when compared with the maturation-      S. typhimurium infection causes stimulation of autoreac-
induced relocation of antigen-loaded Class II MHC. Stim-     tive NKT cells through a combination of endogenous
ulation of antigen-specific CD8 T-cell clones to acquire      GSL presentation via mouse CD1d and PRR-induced
cytotoxic killing of target cells requires as few as three   IL-12 production.43,44 The outer membranes of M. tuber-
peptide–Class I MHC complexes,58 which is one to two         culosis bacilli contain lipid ligands for CD1-mediated
                                                       ¨
orders of magnitude less than required to stimulate naıve    presentation and lipid adjuvants that induce CD1 anti-
CD4 T cells.59,60 Unlike Class II MHC, the trafficking of     gen-processing pathways through TLRs.26,42,70 Finally,
CD1 molecules and the presentation of lipid antigens is      infection of host cells can increase the synthesis of
comparable between both immature and mature                  endogenous GSL and stimulate GSL-specific T cells in a
DCs.25,61,62 TLR-mediated signals stimulate specific anti-    CD1- and TCR-dependent manner, as shown using
gen loading of Class I MHC and CD1 complexes in the          Escherichia coli, Bacilus subtilis, Staphylococcus aureus and
endosomal pathway, with less consequence to the ongoing      Mycobacterium bovis-bacille Calmette Guerin (BCG).73
                                                                                                             ´
surface-directed traffic.                                     Induction of invariant NKT (iNKT)-cell responses upon
   Receptor-mediated uptake effectively introduces antigen   viral infection in mice involves TLR9 signaling and con-
into the cross-presentation pathway, whereas antigen         sequent production of IL-12, while the necessity of
internalized by way of fluid-phase uptake is mostly           CD1d-mediated presentation may not be absolute.74


166                                                              Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170
Regulated presentation of endosome-derived antigens by myeloid dendritic cells

                                                               Yersinia enterocolitica and Klebsiella pneumoniae).83–86
Virus-infection interference with endosomal
                                                               Bacterial products can inhibit the cross-presentation of
antigen presentation mediated by CD1 and Class
                                                               particulate antigen via Class I MHC in a manner that
I MHC
                                                               requires PAMP binding to TLRs and MyD88. Inhibition
DC activation accomplished through TLR ligation, for           of cross-presentation through this route occurs through
example, is pivotal for effective antigen cross-presentation   interference with phagosome maturation and antigen pro-
as discussed above. Infection with certain large viruses       teolysis, as shown for the M. tuberculosis 19 000 MW
that harbor ligands for TLRs can, however, also interfere      lipoprotein, CpG DNA and LPS.87 Moreover, cell wall-
with antigen cross-presentation. The b-herpes virus,           associated alpha-glucan from M. tuberculosis can induce
mouse cytomegalovirus (MCMV), contains immune-                 monocytes to differentiate into DCs that lack CD1 expres-
evasion genes that may affect some aspects of antigen          sion, fail to up-regulate CD80 and produce IL10, render-
cross-presentation as it does for the direct pathway of        ing them unable to prime effector T cells or present lipid
Class I MHC presentation.75 Herpes simplex virus-1             antigens to CD1-restricted T cells.88
(HSV-1) and herpes simplex virus-2 (HSV-2), for exam-
ple, express a protein called ICP47, which blocks peptide
                                                               Interference with CD1-mediated antigen loading
transport via the TAP1/2 transporter.76 Human cytomega-
                                                               in inherited disease
lovirus (HCMV) contains another TAP1/2 inhibitor,
US6.77 The use of a US6-transferrin chimeric molecule          Class II MHC molecules acquire their peptide cargo in
was used to infer the role of TAP1/2 in transporting anti-     specialized compartments of the late endosomal pathway,
genic peptide from the cytosol into phagosomes in the          including MVBs, where the peptide-exchange factor HLA-
process of cross-presentation of phagosomal antigen.5          DM (H2-DM in mice) localizes.89,90 In analogy, late
   Mouse DCs that are infected with MCMV activate              endosomal compartments are enriched for lipid-binding
CD1d-restricted iNKT cells in co-culture systems and           proteins, some of which may function in the exchange of
in vivo.74 Human DCs that are infected with the human          endoplasmic reticulum-derived lipids for antigenic lipids
cytomegalovirus (HCMV) or HSV-1 also up-regulate               onto CD1 molecules (i.e. saposins A, B, C and D) and
antigen presentation via CD1d, which is the only group 2       Niemann-pick type C2 protein.91,92 Saposins function in
CD1 molecule.78 However, HCMV infection of human               a non-enzymatic manner, the exact mechanisms of which
DCs inhibits NKT-cell activation by CD1a, b and c (the         are not yet fully understood. Lack of saposin function
so-called group 1 CD1 molecules), as characterized by          causes lipid storage diseases, such as a form of Krabbe
accumulation of CD1 in endosomal/lysosomal compart-            disease, which develops as a result of saposin A defi-
ments and by the direct measurement of CD1b-restricted         ciency.93 Other known sphingolipid activator proteins are
NKT-cell activation presented by infected DCs.79 One           GM2 and saposins B, C and D, which are all post-transla-
possible explanation for differential responses to viral       tional products of the prosaposin gene.94 Mice that are
insult of group 1 and group 2 CD1 molecules in humans          deficient in prosaposin lack Va14 iNKT cells, yet have a
lies in regulatory elements in the 50 untranslated region,     normal ability to present peptide–Class II MHC com-
which is conserved for group 1 CD1 and distinct for            plexes.95 Deficiencies that involve only proteins for anti-
CD1d.80 At high multiplicity of infection (MOI) of HSV-        gen cross-presentation, while excluding those concerned
1 (MOI of 5–10), however, CD1d-mediated presentation           with the direct pathway of Class I MHC-mediated presen-
is also blocked, possibly through inhibition of CD1d           tation, are to our knowledge yet to be described. Candi-
recycling to the cell surface.72,81                            dates should be found amongst proteins involved with
                                                               the phagosomal milieu, especially those related to antigen
                                                               processing, peptide transport past the phagosomal mem-
Bacterial infection interference with endosomal
                                                               brane and assembly into peptide–Class I MHC complexes.
antigen presentation mediated by CD1 and Class
I MHC
                                                               Concluding remarks
Intracellular bacteria, including mycobacteria, also have
escape mechanisms for antigen presentation mediated by         The mechanisms that support the endosomal processing
Class I MHC or CD1. Bacteria can evade Class II MHC            machinery in professional APCs for presentation of exo-
antigen presentation by infected cells through alteration      genous antigen via Class I MHC or CD1 complexes are
of phagosome–lysosome fusion or biosynthesis, intracellu-      currently being uncovered. It is our hope that new acces-
lar trafficking and surface expression of Class II MHC, as      sory proteins and pivotal mechanisms are found that
recently reviewed.82 Peptide–Class I MHC complex pre-          facilitate selectively, in the endosomal microenviroment,
sentation can be obstructed through interference with the      the sorting of antigen, proteolysis and loading of Class I
surface expression of Class I MHC (e.g. as in infections       MHC and CD1. Elucidation of the endosomal processes
with Chlamydia pneumoniae, Salmonella enteritidis,             that underlie the display of antigen-loaded Class I MHC


Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170                                                            167
M. Boes et al.

and CD1 complexes should yield insights for future thera-               18 Gautier G, Humbert M, Deauvieau F et al. A type I interferon
pies aimed at potentiation of cytotoxic T-cell responses to                autocrine-paracrine loop is involved in Toll-like receptor-
phagocytosed antigens of viral or microbial origin.                        induced interleukin-12p70 secretion by dendritic cells. J Exp
                                                                           Med 2005; 201:1435–46.
                                                                        19 Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R.
Disclosures                                                                TRAM couples endocytosis of Toll-like receptor 4 to the induc-
                                                                           tion of interferon-beta. Nat Immun 2008; 9:361–8.
All authors declare no conflicts of interest.                            20 Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflamma-
                                                                           some: a danger sensing complex triggering innate immunity.
References                                                                 Curr Opin Immunol 2007; 19:615–22.
                                                                        21 Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN,
1 Ueno H, Klechevsky E, Morita R et al. Dendritic cell subsets in          Tschopp J. NALP3 forms an IL-1beta-processing inflammasome
   health and disease. Immunol Rev 2007; 219:118–42.                       with increased activity in Muckle–Wells autoinflammatory disor-
2 Picker LJ, Siegelman MH. in Paul W.E. Fundamental Immunology,            der. Immunity 2004; 20:319–25.
   3rd edn. Philadelphia, PA: Lippinscott Williams & Wilkins, 1993.     22 Wolf PR, Ploegh HL. How MHC class II molecules acquire pep-
3 Bendelac A. Positive selection of mouse NK1 + T cells by                 tide cargo: biosynthesis and trafficking through the endocytic
   CD1-expressing cortical thymocytes. J Exp Med 1995; 182:                pathway. Annu Rev Cell Dev Biol 1995; 11:267–306.
   2091–6.                                                              23 Boes M, Cerny J, Massol R, Op den Brouw M, Kirchhausen T,
4 Sprengers D, Sille FC, Derkow K, Besra GS, Janssen HL, Schott            Chen J, Ploegh HL. T-cell engagement of dendritic cells rapidly
   E, Boes M. Critical role for CD1d-restricted invariant NKT cells        rearranges MHC class II transport. Nature 2002; 418:983–8.
   in stimulating intrahepatic CD8 T-cell responses to liver antigen.   24 Chow A, Toomre D, Garrett W, Mellman I. Dendritic cell matu-
   Gastroenterology 2008; 134:2132–43.                                     ration triggers retrograde MHC class II transport from lyso-
5 Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. Spatial and             somes to the plasma membrane. Nature 2002; 418:988–94.
   mechanistic separation of cross-presentation and endogenous          25 van der Wel NN, Sugita M, Fluitsma DM, Cao X, Schreibelt G,
   antigen presentation. Nat Immun 2008; 9:558–66.                         Brenner MB, Peters PJ. CD1 and major histocompatibility com-
6 Sugita M, Grant EP, van Donselaar E, Hsu VW, Rogers RA,                  plex II molecules follow a different course during dendritic cell
   Peters PJ, Brenner MB. Separate pathways for antigen presenta-          maturation. Mol Biol Cell 2003; 14:3378–88.
   tion by CD1 molecules. Immunity 1999; 11:743–52.                     26 Skold M, Xiong X, Illarionov PA, Besra GS, Behar SM. Interplay
7 Bradbury A, Calabi F, Milstein C. Expression of CD1 in the               of cytokines and microbial signals in regulation of CD1d expres-
   mouse thymus. Eur J Immunol 1990; 20:1831–6.                            sion and NKT cell activation. J Immunol 2005; 175:3584–93.
8 de la Salle H, Mariotti S, Angenieux C et al. Assistance of           27 Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Early phago-
   microbial glycolipid antigen processing by CD1e. Science (New           somes in dendritic cells form a cellular compartment sufficient
   York, NY) 2005; 310:1321–4.                                             for cross presentation of exogenous antigens. Proc Natl Acad Sci
9 Bendelac A, Savage PB, Teyton L. The biology of NKT cells.               USA 2003; 100:12889–94.
   Annu Rev Immunol 2007; 25:297–336.                                   28 Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Access of solu-
10 Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L. Crys-            ble antigens to the endoplasmic reticulum can explain cross-
   tal structures of mouse CD1d-iGb3 complex and its cognate               presentation by dendritic cells. Nat Immun 2005; 6:107–13.
   Valpha14 T cell receptor suggest a model for dual recognition of     29 Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert
   foreign and self glycolipids. J Mol Biol 2008; 377:1104–16.             P, Amigorena S. ER-phagosome fusion defines an MHC class I
11 Bouvier M, Wiley DC. Importance of peptide amino and car-               cross-presentation compartment in dendritic cells. Nature 2003;
   boxyl termini to the stability of MHC class I molecules. Science        425:397–402.
   (New York, NY) 1994; 265:398–402.                                    30 Houde M, Bertholet S, Gagnon E et al. Phagosomes are competent
12 Rammensee HG. Chemistry of peptides associated with MHC                 organelles for antigen cross-presentation. Nature 2003; 425:402–6.
   class I and class II molecules. Curr Opin Immunol 1995; 7:85–96.     31 Vega MA, Strominger JL. Constitutive endocytosis of HLA class
13 Moody DB, Reinhold BB, Guy MR et al. Structural requirements            I antigens requires a specific portion of the intracytoplasmic tail
   for glycolipid antigen recognition by CD1b-restricted T cells.          that shares structural features with other endocytosed molecules.
   Science (New York, NY) 1997; 278:283–6.                                 Proc Natl Acad Sci USA 1989; 86:2688–92.
14 Banchereau J, Steinman RM. Dendritic cells and the control of        32 Reid PA, Watts C. Cycling of cell-surface MHC glycoproteins
   immunity. Nature 1998; 392:245–52.                                      through primaquine-sensitive intracellular compartments. Nature
15 Heath WR, Belz GT, Behrens GM et al. Cross-presentation, den-           1990; 346:655–7.
   dritic cell subsets, and the generation of immunity to cellular      33 Delamarre L, Holcombe H, Mellman I. Presentation of exoge-
   antigens. Immunol Rev 2004; 199:9–26.                                   nous antigens on major histocompatibility complex (MHC) class
16 van der Aar AM, Sylva-Steenland RM, Bos JD, Kapsenberg ML,              I and MHC class II molecules is differentially regulated during
   de Jong EC, Teunissen MB. Loss of TLR2, TLR4, and TLR5 on               dendritic cell maturation. J Exp Med 2003; 198:111–22.
   Langerhans cells abolishes bacterial recognition. J Immunol 2007;    34 Blander JM, Medzhitov R. On regulation of phagosome matura-
   178:1986–90.                                                            tion and antigen presentation. Nat Immun 2006; 7:1029–35.
17 Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A.      35 Savina A, Amigorena S. Phagocytosis and antigen presentation
   Selected Toll-like receptor agonist combinations synergistically        in dendritic cells. Immunol Rev 2007; 219:143–56.
   trigger a T helper type 1-polarizing program in dendritic cells.     36 Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES.
   Nat Immun 2005; 6:769–76.                                               Differential lysosomal proteolysis in antigen-presenting cells


168                                                                         Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170
Regulated presentation of endosome-derived antigens by myeloid dendritic cells

     determines antigen fate. Science (New York, NY) 2005; 307:           55 Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-
     1630–4.                                                                 Castagnoli P, Raposo G, Amigorena S. Molecular characteriza-
37   Lennon-Dumenil AM, Bakker AH, Maehr R, Fiebiger E, Over-                tion of dendritic cell-derived exosomes. Selective accumulation
     kleeft HS, Rosemblatt M, Ploegh HL, Lagaudriere-Gesbert C.              of the heat shock protein hsc73. J Cell Biol 1999; 147:599–610.
     Analysis of protease activity in live antigen-presenting cells       56 Inaba K, Turley S, Iyoda T et al. The formation of immunogenic
     shows regulation of the phagosomal proteolytic contents during          major histocompatibility complex class II-peptide ligands in
     dendritic cell activation. J Exp Med 2002; 196:529–40.                  lysosomal compartments of dendritic cells is regulated by
38   Savina A, Jancic C, Hugues S et al. NOX2 controls phagosomal            inflammatory stimuli. J Exp Med 2000; 191:927–36.
     pH to regulate antigen processing during crosspresentation by        57 Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflam-
     dendritic cells. Cell 2006; 126:205–18.                                 matory stimuli induce accumulation of MHC class II complexes
39   Kim SH, Visser A, Cruijsen C, van der Velden AW, Boes M.                on dendritic cells. Nature 1997; 388:782–7.
     Recruitment of Rab27a to phagosomes controls microbial anti-         58 Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing
     gen cross-presentation by dendritic cells. Infect Immun 2008;           does not require the formation of a stable mature immunologi-
     76:5373–80.                                                             cal synapse. Nat Immun 2004; 5:524–30.
40   Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1                  59 Harding CV, Unanue ER. Quantitation of antigen-presenting cell
     delivers nucleotide-sensing toll-like receptors to endolysosomes.       MHC class II/peptide complexes necessary for T-cell stimulation.
     Nature 2008; 452:234–8.                                                 Nature 1990; 346:574–6.
41   Blander JM, Medzhitov R. Regulation of phagosome maturation          60 Demotz S, Grey HM, Sette A. The minimal number of class II
     by signals from toll-like receptors. Science (New York, NY) 2004;       MHC-antigen complexes needed for T cell activation. Science
     304:1014–18.                                                            (New York, NY) 1990; 249:1028–30.
42   Roura-Mir C, Wang L, Cheng TY et al. Mycobacterium tuber-            61 Cao X, Sugita M, Van Der Wel N, Lai J, Rogers RA, Peters PJ,
     culosis regulates CD1 antigen presentation pathways through             Brenner MB. CD1 molecules efficiently present antigen in
     TLR-2. J Immunol 2005; 175:1758–66.                                     immature dendritic cells and traffic independently of MHC class
43   Mattner J, Debord KL, Ismail N et al. Exogenous and endoge-             II during dendritic cell maturation. J Immunol 2002; 169:
     nous glycolipid antigens activate NKT cells during microbial            4770–7.
     infections. Nature 2005; 434:525–9.                                  62 Hava DL, van der Wel N, Cohen N et al. Evasion of peptide,
44   Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism              but not lipid antigen presentation, through pathogen-induced
     of CD1d-restricted natural killer T cell activation during micro-       dendritic cell maturation. Proc Natl Acad Sci USA 2008;
     bial infection. Nat Immun 2003; 4:1230–7.                               105:11281–6.
45   Kumagai Y, Takeuchi O, Akira S. Pathogen recognition by              63 Amigorena S, Bonnerot C. Fc receptors for IgG and antigen pre-
     innate receptors. J Infect Chemother 2008; 14:86–92.                    sentation on MHC class I and class II molecules. Semin Immu-
46   Palliser D, Ploegh H, Boes M. Myeloid differentiation factor 88 is      nol 1999; 11:385–90.
     required for cross-priming in vivo. J Immunol 2004; 172:3415–21.     64 Jancic C, Savina A, Wasmeier C et al. Rab27a regulates phagoso-
47   Lin ML, Zhan Y, Villadangos JA, Lew AM. The cell biology of             mal pH and NADPH oxidase recruitment to dendritic cell
     cross-presentation and the role of dendritic cell subsets. Immu-        phagosomes. Nat Cell Biol 2007; 9:367–78.
     nol Cell Biol 2008; 86:353–62.                                       65 Hunger RE, Sieling PA, Ochoa MT et al. Langerhans cells utilize
48   Kleijmeer M, Ramm G, Schuurhuis D et al. Reorganization of              CD1a and langerin to efficiently present nonpeptide antigens to
     multivesicular bodies regulates MHC class II antigen presenta-          T cells. J Clin Invest 2004; 113:701–8.
     tion by dendritic cells. J Cell Biol 2001; 155:53–63.                66 Tailleux L, Schwartz O, Herrmann JL et al. DC-SIGN is the
49   Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T,               major Mycobacterium tuberculosis receptor on human dendritic
     Ploegh H. T cells induce extended class II MHC compartments             cells. J Exp Med 2003; 197:121–7.
     in dendritic cells in a Toll-like receptor-dependent manner.         67 Prigozy TI, Sieling PA, Clemens D et al. The mannose receptor
     J Immunol 2003; 171:4081–8.                                             delivers lipoglycan antigens to endosomes for presentation to T
50   Kleijmeer MJ, Escola JM, UytdeHaag FG et al. Antigen loading            cells by CD1b molecules. Immunity 1997; 6:187–97.
     of MHC class I molecules in the endocytic tract. Traffic 2001;        68 van den Elzen P, Garg S, Leon L et al. Apolipoprotein-medi-
     2:124–37.                                                               ated pathways of lipid antigen presentation. Nature 2005;
51   Vyas JM, Kim YM, Artavanis-Tsakonas K, Love JC, Van der                 437:906–10.
     Veen AG, Ploegh HL. Tubulation of class II MHC compart-              69 Yrlid U, Wick MJ. Salmonella-induced apoptosis of infected
     ments is microtubule dependent and involves multiple endo-              macrophages results in presentation of a bacteria-encoded anti-
     lysosomal membrane proteins in primary dendritic cells.                 gen after uptake by bystander dendritic cells. J Exp Med 2000;
     J Immunol 2007; 178:7199–210.                                           191:613–24.
52   Schulz O, Diebold SS, Chen M et al. Toll-like receptor 3 pro-        70 Schaible UE, Winau F, Sieling PA et al. Apoptosis facilitates
     motes cross-priming to virus-infected cells. Nature 2005;               antigen presentation to T lymphocytes through MHC-I and CD1
     433:887–92.                                                             in tuberculosis. Nat Med 2003; 9:1039–46.
53   Warger T, Osterloh P, Rechtsteiner G et al. Synergistic activation   71 Trajkovic K, Hsu C, Chiantia S et al. Ceramide triggers budding
     of dendritic cells by combined Toll-like receptor ligation induces      of exosome vesicles into multivesicular endosomes. Science (New
     superior CTL responses in vivo. Blood 2006; 108:544–50.                 York, NY) 2008; 319:1244–7.
54   Gromme M, Uytdehaag FG, Janssen H et al. Recycling MHC               72 Yuan W, Dasgupta A, Cresswell P. Herpes simplex virus evades
     class I molecules and endosomal peptide loading. Proc Natl Acad         natural killer T cell recognition by suppressing CD1d recycling.
     Sci U S A 1999; 96:10326–31.                                            Nat Immun 2006; 7:835–42.


Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170                                                                               169
M. Boes et al.

73 De Libero G, Moran AP, Gober HJ et al. Bacterial infections             is instrumental for Mycobacterium tuberculosis to block CD1
   promote T cell recognition of self-glycolipids. Immunity 2005;          molecule expression and disable the function of dendritic cell
   22:763–72.                                                              derived from infected monocyte. Cell Microbiol 2007; 9:2081–92.
74 Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, Kro-         89 Sanderson F, Kleijmeer MJ, Kelly A, Verwoerd D, Tulp A, Neef-
   nenberg M. Cutting edge: the mechanism of invariant NKT cell            jes JJ, Geuze HJ, Trowsdale J. Accumulation of HLA-DM, a reg-
   responses to viral danger signals. J Immunol 2008; 181:4452–6.          ulator of antigen presentation, in MHC class II compartments.
75 Yewdell JW, Hill AB. Viral interference with antigen presenta-          Science (New York, NY) 1994; 266:1566–9.
   tion. Nat Immun 2002; 3:1019–25.                                    90 Kleijmeer MJ, Raposo G, Geuze HJ. Characterization of MHC
76 Galocha B, Hill A, Barnett BC et al. The active site of ICP47, a        class II compartments by immunoelectron microscopy. Methods
   herpes simplex virus-encoded inhibitor of the major histocom-           1996; 10:191–207.
   patibility complex (MHC)-encoded peptide transporter associ-        91 Locatelli-Hoops S, Remmel N, Klingenstein R et al. Saposin A
   ated with antigen processing (TAP), maps to the NH2-terminal            mobilizes lipids from low cholesterol and high bis(monoa-
   35 residues. J Exp Med 1997; 185:1565–72.                               cylglycerol)phosphate-containing membranes: patient variant
77 Hengel H, Flohr T, Hammerling GJ, Koszinowski UH, Mom-                  Saposin A lacks lipid extraction capacity. J Biol Chem 2006;
   burg F. Human cytomegalovirus inhibits peptide translocation            281:32451–60.
   into the endoplasmic reticulum for MHC class I assembly. J Gen      92 Schrantz N, Sagiv Y, Liu Y, Savage PB, Bendelac A, Teyton L.
   Virol 1996; 9:2287–96.                                                  The Niemann-Pick type C2 protein loads isoglobotrihexosylcera-
78 Raftery MJ, Winau F, Giese T, Kaufmann SH, Schaible UE,                 mide onto CD1d molecules and contributes to the thymic selec-
   Schonrich G. Viral danger signals control CD1d de novo synthe-          tion of NKT cells. J Exp Med 2007; 204:841–52.
   sis and NKT cell activation. Eur J Immunol 2008; 38:668–79.         93 Spiegel R, Bach G, Sury V et al. A mutation in the saposin A
79 Raftery MJ, Hitzler M, Winau F, Giese T, Plachter B, Kaufmann           coding region of the prosaposin gene in an infant presenting as
   SH, Schonrich G. Inhibition of CD1 antigen presentation by              Krabbe disease: first report of saposin A deficiency in humans.
   human cytomegalovirus. J Virol 2008; 82:4308–19.                        Mol Genet Metab 2005; 84:160–6.
80 Balk SP, Bleicher PA, Terhorst C. Isolation and characterization    94 Vielhaber G, Hurwitz R, Sandhoff K. Biosynthesis, processing,
   of a cDNA and gene coding for a fourth CD1 molecule. Proc               and targeting of sphingolipid activator protein (SAP)precursor
   Natl Acad Sci USA 1989; 86:252–6.                                       in cultured human fibroblasts. Mannose 6-phosphate receptor-
81 Raftery MJ, Winau F, Kaufmann SH, Schaible UE, Schonrich G.             independent endocytosis of SAP precursor. J Biol Chem 1996;
   CD1 antigen presentation by human dendritic cells as a target           271:32438–46.
   for herpes simplex virus immune evasion. J Immunol 2006;            95 Zhou D, Cantu C 3rd, Sagiv Y et al. Editing of CD1d-bound
   177:6207–14.                                                            lipid antigens by endosomal lipid transfer proteins. Science (New
82 Harding CV, Ramachandra L, Wick MJ. Interaction of bacteria             York, NY) 2004; 303:523–7.
   with antigen presenting cells: influences on antigen presentation    96 Joyce S, Woods AS, Yewdell JW et al. Natural ligand of mouse
   and antibacterial immunity. Curr Opin Immunol 2003; 15:112–             CD1d1: cellular glycosylphosphatidylinositol. Science (New York,
   19.                                                                     NY) 1998; 279:1541–4.
83 Huang F, Yamaguchi A, Tsuchiya N et al. Induction of alterna-       97 Park JJ, Kang SJ, De Silva AD, Stanic AK, Casorati G, Hachey
   tive splicing of HLA-B27 by bacterial invasion. Arthritis Rheum         DL, Cresswell P, Joyce S. Lipid-protein interactions: biosynthetic
   1997; 40:694–703.                                                       assembly of CD1 with lipids in the endoplasmic reticulum is
84 Kirveskari J, He Q, Leirisalo-Repo M, Maki-Ikola O, Wuorela             evolutionarily conserved. Proc Natl Acad Sci USA 2004;
   M, Putto-Laurila A, Granfors K. Enterobacterial infection modu-         101:1022–6.
   lates major histocompatibility complex class I expression on        98 Cresswell P, Bangia N, Dick T, Diedrich G. The nature of the
   mononuclear cells. Immunology 1999; 97:420–8.                           MHC class I peptide loading complex. Immunol Rev 1999;
85 Wuorela M, Jalkanen S, Kirveskari J, Laitio P, Granfors K. Yer-         172:21–8.
   sinia enterocolitica serotype O:3 alters the expression of sero-    99 Kang SJ, Cresswell P. Calnexin, calreticulin, and ERp57 cooper-
   logic HLA-B27 epitopes on human monocytes. Infect Immun                 ate in disulfide bond formation in human CD1d heavy chain.
   1997; 65:2060–6.                                                        J Biol Chem 2002; 277:44838–44.
86 Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcrip-       100 Brozovic S, Nagaishi T, Yoshida M et al. CD1d function is regu-
   tion factor RFX5 during the inhibition of both constitutive and         lated by microsomal triglyceride transfer protein. Nat Med 2004;
   interferon gamma-inducible major histocompatibility complex             10:535–9.
   class I expression in chlamydia-infected cells. J Exp Med 2000;     101 Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mel-
   191:1525–34.                                                            lins E, Zaller DM. Mediation by HLA-DM of dissociation of
87 Tobian AA, Potter NS, Ramachandra L, Pai RK, Convery M,                 peptides from HLA-DR. Nature 1995; 375:802–6.
   Boom WH, Harding CV. Alternate class I MHC antigen process-         102 Boes M, Cuvillier A, Ploegh H. Membrane specializations and
   ing is inhibited by Toll-like receptor signaling pathogen-associ-       endosome maturation in dendritic cells and B cells. Trends Cell
   ated molecular patterns: Mycobacterium tuberculosis 19-kDa              Biol 2004; 14:175–83.
   lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003;       103 Sagiv Y, Bai L, Wei DG, Agami R, Savage PB, Teyton L, Bende-
   171:1413–22.                                                            lac A. A distal effect of microsomal triglyceride transfer protein
88 Gagliardi MC, Lemassu A, Teloni R, Mariotti S, Sargentini V,            deficiency on the lysosomal recycling of CD1d. J Exp Med 2007;
   Pardini M, Daffe M, Nisini R. Cell wall-associated alpha-glucan         204:921–8.




170                                                                        Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170

More Related Content

What's hot

MHC MOLECULES
MHC MOLECULESMHC MOLECULES
MHC MOLECULES
preeti337
 

What's hot (19)

17.histocompatability complex
17.histocompatability complex17.histocompatability complex
17.histocompatability complex
 
Major Histocompatibility Complex (MHC)
Major Histocompatibility Complex (MHC)Major Histocompatibility Complex (MHC)
Major Histocompatibility Complex (MHC)
 
Ag presentation & role of mhc somu
Ag presentation & role of mhc somuAg presentation & role of mhc somu
Ag presentation & role of mhc somu
 
Major histocompatibility complex
Major histocompatibility complexMajor histocompatibility complex
Major histocompatibility complex
 
Rendon MHC presentation, A Brief Introduction.
Rendon MHC presentation, A Brief Introduction. Rendon MHC presentation, A Brief Introduction.
Rendon MHC presentation, A Brief Introduction.
 
Major Histocompatibility complex
Major Histocompatibility complexMajor Histocompatibility complex
Major Histocompatibility complex
 
Mhc hla
Mhc hlaMhc hla
Mhc hla
 
MHC description
MHC descriptionMHC description
MHC description
 
Antigen processing and presentation. Antigen – Antibody Interaction.
Antigen processing and presentation. Antigen – Antibody Interaction.Antigen processing and presentation. Antigen – Antibody Interaction.
Antigen processing and presentation. Antigen – Antibody Interaction.
 
MHC MOLECULES
MHC MOLECULESMHC MOLECULES
MHC MOLECULES
 
Mhc
MhcMhc
Mhc
 
MHC
MHCMHC
MHC
 
Mhc and disease susceptibility
Mhc and disease susceptibilityMhc and disease susceptibility
Mhc and disease susceptibility
 
Mhc lecture notes
Mhc lecture notesMhc lecture notes
Mhc lecture notes
 
MHC, Superantigens
MHC, SuperantigensMHC, Superantigens
MHC, Superantigens
 
Major Histocompatibility Complex (MHC)
Major Histocompatibility Complex (MHC)Major Histocompatibility Complex (MHC)
Major Histocompatibility Complex (MHC)
 
MAJOR HISTOCOMPATIBILITY COMPLEX
MAJOR HISTOCOMPATIBILITY COMPLEXMAJOR HISTOCOMPATIBILITY COMPLEX
MAJOR HISTOCOMPATIBILITY COMPLEX
 
Basic immunity
Basic immunityBasic immunity
Basic immunity
 
MHC
MHC MHC
MHC
 

Similar to 4 cd1

Antigen processing lecture-nkn
Antigen processing  lecture-nknAntigen processing  lecture-nkn
Antigen processing lecture-nkn
Navreet Nanda
 
Major histocompatibility complex
Major histocompatibility complexMajor histocompatibility complex
Major histocompatibility complex
Jyoti Sharma
 

Similar to 4 cd1 (20)

Immunology
ImmunologyImmunology
Immunology
 
MHC
MHCMHC
MHC
 
Mhc
MhcMhc
Mhc
 
Major Histocompatibility Complex
Major Histocompatibility Complex Major Histocompatibility Complex
Major Histocompatibility Complex
 
Basic immunology from the dermatologic point of view (adaptive immunity)
Basic immunology from the dermatologic point of view (adaptive immunity)Basic immunology from the dermatologic point of view (adaptive immunity)
Basic immunology from the dermatologic point of view (adaptive immunity)
 
Antigen processing lecture-nkn
Antigen processing  lecture-nknAntigen processing  lecture-nkn
Antigen processing lecture-nkn
 
Basics of Immunity
Basics of ImmunityBasics of Immunity
Basics of Immunity
 
Adaptive Immune Response to Viral Infections
Adaptive Immune Response to Viral InfectionsAdaptive Immune Response to Viral Infections
Adaptive Immune Response to Viral Infections
 
4 basic-immunology
4 basic-immunology4 basic-immunology
4 basic-immunology
 
Antigen presenting cells
Antigen presenting cellsAntigen presenting cells
Antigen presenting cells
 
MHC MOLECULE
MHC MOLECULEMHC MOLECULE
MHC MOLECULE
 
Major histocompatibility complex
Major histocompatibility complexMajor histocompatibility complex
Major histocompatibility complex
 
M H C
M H CM H C
M H C
 
Advanced Immunology: Antigen Processing and Presentation
Advanced Immunology: Antigen Processing and PresentationAdvanced Immunology: Antigen Processing and Presentation
Advanced Immunology: Antigen Processing and Presentation
 
ANTIGEN PRESENTING CELL
ANTIGEN PRESENTING CELLANTIGEN PRESENTING CELL
ANTIGEN PRESENTING CELL
 
G.2014-immuno~ (9.apc-jyh)
 G.2014-immuno~ (9.apc-jyh) G.2014-immuno~ (9.apc-jyh)
G.2014-immuno~ (9.apc-jyh)
 
Mhc And Antigens
Mhc And AntigensMhc And Antigens
Mhc And Antigens
 
Adaptive immunity.pptx
Adaptive immunity.pptxAdaptive immunity.pptx
Adaptive immunity.pptx
 
Cells of immune system
Cells of immune systemCells of immune system
Cells of immune system
 
Chapter 29 dendritic cells
Chapter 29 dendritic cellsChapter 29 dendritic cells
Chapter 29 dendritic cells
 

More from ufamimunologia

5 linfócitos b e receptores do tipo toll
5 linfócitos b e receptores do tipo toll5 linfócitos b e receptores do tipo toll
5 linfócitos b e receptores do tipo toll
ufamimunologia
 
5 seleção de linfócitos t reg
5 seleção de linfócitos t reg5 seleção de linfócitos t reg
5 seleção de linfócitos t reg
ufamimunologia
 
3 moléculas acessórias de toll
3 moléculas acessórias de toll3 moléculas acessórias de toll
3 moléculas acessórias de toll
ufamimunologia
 
2 complemento -segunda apresentação
2 complemento -segunda apresentação2 complemento -segunda apresentação
2 complemento -segunda apresentação
ufamimunologia
 
2 complemento receptores - segunda apresentação
2  complemento receptores - segunda apresentação2  complemento receptores - segunda apresentação
2 complemento receptores - segunda apresentação
ufamimunologia
 
1 basófilo e mastócitos - primeira apresentação
1  basófilo e mastócitos - primeira apresentação1  basófilo e mastócitos - primeira apresentação
1 basófilo e mastócitos - primeira apresentação
ufamimunologia
 
2 complemento e imunidades -segunda apresentação
2 complemento e imunidades -segunda apresentação2 complemento e imunidades -segunda apresentação
2 complemento e imunidades -segunda apresentação
ufamimunologia
 
1 células dendríticas - primeira apresentação
1 células dendríticas - primeira apresentação1 células dendríticas - primeira apresentação
1 células dendríticas - primeira apresentação
ufamimunologia
 
1 histórico das células dendríticas - primeira apresentação.pdf
1 histórico das células dendríticas - primeira apresentação.pdf1 histórico das células dendríticas - primeira apresentação.pdf
1 histórico das células dendríticas - primeira apresentação.pdf
ufamimunologia
 
1 basófilo e mastócitos - primeira apresentação
1  basófilo e mastócitos - primeira apresentação1  basófilo e mastócitos - primeira apresentação
1 basófilo e mastócitos - primeira apresentação
ufamimunologia
 
1 neutrófilos - primeira apresentação.pdf
1  neutrófilos - primeira apresentação.pdf1  neutrófilos - primeira apresentação.pdf
1 neutrófilos - primeira apresentação.pdf
ufamimunologia
 
1 basófilo e mastócitos - primeira apresentação
1  basófilo e mastócitos - primeira apresentação1  basófilo e mastócitos - primeira apresentação
1 basófilo e mastócitos - primeira apresentação
ufamimunologia
 

More from ufamimunologia (20)

5 n fkapa b
5 n fkapa b5 n fkapa b
5 n fkapa b
 
5 linfócitos t
5 linfócitos t5 linfócitos t
5 linfócitos t
 
5 linfócitos b
5 linfócitos b5 linfócitos b
5 linfócitos b
 
5 linfócitos b e receptores do tipo toll
5 linfócitos b e receptores do tipo toll5 linfócitos b e receptores do tipo toll
5 linfócitos b e receptores do tipo toll
 
5 seleção de linfócitos t reg
5 seleção de linfócitos t reg5 seleção de linfócitos t reg
5 seleção de linfócitos t reg
 
4 cd1a reciclagem
4 cd1a reciclagem4 cd1a reciclagem
4 cd1a reciclagem
 
4 cd1 nature
4 cd1 nature4 cd1 nature
4 cd1 nature
 
3 prr
3 prr3 prr
3 prr
 
3 nod
3 nod3 nod
3 nod
 
3 moléculas acessórias de toll
3 moléculas acessórias de toll3 moléculas acessórias de toll
3 moléculas acessórias de toll
 
4 mhc -ii
4 mhc -ii4 mhc -ii
4 mhc -ii
 
2 complemento -segunda apresentação
2 complemento -segunda apresentação2 complemento -segunda apresentação
2 complemento -segunda apresentação
 
2 complemento receptores - segunda apresentação
2  complemento receptores - segunda apresentação2  complemento receptores - segunda apresentação
2 complemento receptores - segunda apresentação
 
1 basófilo e mastócitos - primeira apresentação
1  basófilo e mastócitos - primeira apresentação1  basófilo e mastócitos - primeira apresentação
1 basófilo e mastócitos - primeira apresentação
 
2 complemento e imunidades -segunda apresentação
2 complemento e imunidades -segunda apresentação2 complemento e imunidades -segunda apresentação
2 complemento e imunidades -segunda apresentação
 
1 células dendríticas - primeira apresentação
1 células dendríticas - primeira apresentação1 células dendríticas - primeira apresentação
1 células dendríticas - primeira apresentação
 
1 histórico das células dendríticas - primeira apresentação.pdf
1 histórico das células dendríticas - primeira apresentação.pdf1 histórico das células dendríticas - primeira apresentação.pdf
1 histórico das células dendríticas - primeira apresentação.pdf
 
1 basófilo e mastócitos - primeira apresentação
1  basófilo e mastócitos - primeira apresentação1  basófilo e mastócitos - primeira apresentação
1 basófilo e mastócitos - primeira apresentação
 
1 neutrófilos - primeira apresentação.pdf
1  neutrófilos - primeira apresentação.pdf1  neutrófilos - primeira apresentação.pdf
1 neutrófilos - primeira apresentação.pdf
 
1 basófilo e mastócitos - primeira apresentação
1  basófilo e mastócitos - primeira apresentação1  basófilo e mastócitos - primeira apresentação
1 basófilo e mastócitos - primeira apresentação
 

Recently uploaded

CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
giselly40
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
Earley Information Science
 

Recently uploaded (20)

04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men08448380779 Call Girls In Friends Colony Women Seeking Men
08448380779 Call Girls In Friends Colony Women Seeking Men
 
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdfThe Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
The Role of Taxonomy and Ontology in Semantic Layers - Heather Hedden.pdf
 
CNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of ServiceCNv6 Instructor Chapter 6 Quality of Service
CNv6 Instructor Chapter 6 Quality of Service
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
The Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptxThe Codex of Business Writing Software for Real-World Solutions 2.pptx
The Codex of Business Writing Software for Real-World Solutions 2.pptx
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Advantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your BusinessAdvantages of Hiring UIUX Design Service Providers for Your Business
Advantages of Hiring UIUX Design Service Providers for Your Business
 
Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...Driving Behavioral Change for Information Management through Data-Driven Gree...
Driving Behavioral Change for Information Management through Data-Driven Gree...
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptxEIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
EIS-Webinar-Prompt-Knowledge-Eng-2024-04-08.pptx
 
Slack Application Development 101 Slides
Slack Application Development 101 SlidesSlack Application Development 101 Slides
Slack Application Development 101 Slides
 
Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024Finology Group – Insurtech Innovation Award 2024
Finology Group – Insurtech Innovation Award 2024
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time AutomationFrom Event to Action: Accelerate Your Decision Making with Real-Time Automation
From Event to Action: Accelerate Your Decision Making with Real-Time Automation
 

4 cd1

  • 1. IMMUNOLOGY REVIEW ARTICLE Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction Marianne Boes,1,2 Arie J. Summary Stoppelenburg1 and The presentation of antigen in a form that can be recognized by T lym- Fenna C. M. Sille2 ´ 1 phocytes of the immune system requires antigen processing and associa- Department of Pediatric Immunology, Univer- tion of antigen-derived fragments with molecules encoded by the major sity Medical Center Utrecht, Wilhelmina Children’s Hospital, Utrecht, the Netherlands, histocompatibility complex (MHC) locus or by the CD1 locus. Much and 2Department of Dermatology, Brigham emphasis on antigen processing and presentation in the last decades has and Women’s Hospital and Harvard Medical focused on what we consider ‘conventional routes’ of antigen processing School, Boston, MA, USA and presentation, whereby extracellular antigens are processed for presen- tation via Class II MHC complexes and cytosolic antigens are presented as peptide–Class I MHC complexes. We here highlight two other path- ways in myeloid dendritic cells, those of lipid antigen presentation in association with CD1 and of peptide cross-presentation via Class I MHC complexes. Some pathogens evade immune recognition through inhibition doi:10.1111/j.1365-2567.2009.03078.x of antigen presentation of phagosomal origin. Deviations in endosomal Received 14 November 2008; revised 15 antigen processing and presentation are also seen in individuals suffering January 2009, 2 February 2009; accepted 4 from glycosphingolipid lysosomal lipid storage diseases. We summarize February 2009. Correspondence: M. Boes, Department of recent developments in the endosomal antigen processing and presenta- Pediatric Immunology, University Medical tion pathway, for display as lipid–CD1 complexes to natural killer T cells Center Utrecht, Wilhelmina Children’s and as peptide–Class I MHC complexes to CD8 T cells. Hospital, Utrecht, the Netherlands. Email: mboes@umcutrecht.nl Keywords: CD1d; cross-presentation; endosome; major histocompatibility Senior author: Marianne Boes complex Class I; myeloid dendritic cell chain [of approximately 43 000–49 000 molecular weight Introduction (MW)] that assembles with b2-microglobulin The initiation of strong adaptive immune responses that (12 000 MW) and endogenous peptide or lipid in the yield memory requires the processing and presentation of endoplasmic reticulum, respectively. Exogenous antigens antigen as peptide–major histocompatibility complex provide alternative sources of peptides for Class I MHC, (MHC) complexes or as lipid–CD1 complexes to T lym- for loading in phagosomes.5 The number of CD1 iso- phocytes.1 Class I MHC is expressed on most nucleated forms expressed varies among species: humans express cells, whereas CD1 expression and Class II MHC expres- several antigen-presenting isoforms of CD1 – CD1a, sion are more restricted, being constitutive on profes- CD1b, CD1c and CD1d – that complement one another sional antigen-presenting cells (APCs) [i.e. on dendritic in the sampling of antigen from various endosomal com- cells (DCs), B cells and macrophages]. Thymic selection partments,6 whereas mice only express the CD1d iso- of MHC-restricted T lymphocytes occurs by presentation form.7 Humans additionally express CD1e, which during of peptide–MHC complexes on thymic stroma cells, while DC maturation translocates from the Golgi to lysosomes, selection of CD1-restricted natural killer T cells (NKT where CD1e is thought to facilitate the selection of anti- cells) occurs on CD1-expressing cortical thymocytes, as genic lipids for surface display via other members of the shown in mice.23 MHC-restricted T cells require clonal CD1 family.8 expansion to execute key roles in adaptive immune Much of what is known to date about CD1-mediated responses, whereas CD1-restricted NKT cells act within antigen presentation and T-cell selection is obtained from hours of stimulation by secreting polarizing cytokines.4 mouse-based experiments. Semi-invariant NKT cells rep- Class I MHC and CD1 molecules both contain one heavy resent approximately 80% of all CD1d-restricted T cells Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170 163
  • 2. M. Boes et al. in mice and express a T-cell receptor (TCR) that contains ing of pathogen-recognition receptors often coincides a Va14-Ja18 assembled with Vb8, Vb7 and Vb2-contain- with the ligation of receptors to inflammatory cytokines, ing TCR b chains.9 Antigens recognized by semi-invariant for example interferon-c (IFN-c) and tumour necrosis NKT cells are derived from lipid membranes in endo- factor-a (TNF-a), on DCs. Signals integrated from these somes and lysosomes from foreign or host origin.9 As can receptors instigate in DCs the rearrangement of the anti- be expected from the cargo loaded into the antigen-bind- gen processing and presentation machinery in endosomes ing grooves, the hydrophobic CD1d-binding groove for induced cell-surface display of antigenic peptide– contains two large cavities that facilitate the binding of MHC and lipid–CD1 complexes. non-polar alkyl chains and exposes the polar glycolipid headgroup,10 whereas MHC molecules harbour a groove Pathogen recognition receptors as modulators of that is lined with charged residues to facilitate the binding endosomal antigen processing of peptide anchor residues.11,12 Some peptides can bind CD1 and these are overall hydrophobic in character. The Ligation of receptors specific for pathogen-associated MHC locus is polygenic (> 200 genes in human) and molecular patterns (PAMPs) expressed by DCs deliver sig- exceptionally polymorphic, whereas CD1 gene products nals that can stimulate the differentiation of DCs from are monogenic or have a very limited range of alleles. The being primarily phagocytic sentinels into potent APCs single CD1d protein that is expressed in mice, however, capable of T-cell stimulation. These receptors are collec- can adopt different conformations that facilitate the bind- tively called pattern recognition receptors (PRRs) and ing of related ceramides from endogenous and acquired include three major families: Toll-like receptors (TLRs); sources (i.e. iGb3 and alpha-Galactosyl ceramide),10 intracytoplasmic nucleotide oligomerization domain thereby allowing the presentation of multiple antigens. (NOD)-like receptors; and cell-surface C-type lectin recep- One can imagine that other CD1 isoforms may take on tors. DCs can also be activated indirectly by capture of frag- multiple conformations as mouse CD1d does: human ments of cells that died in response to infection or tissue CD1b can present glucose monomycolates that vary sig- injury. DCs express selected sets of PRRs belonging to these nificantly in their lipid tail fine structures and overall receptor families, the composition of which helps focus the lengths,13 a capability that may be attributable to confor- type of adaptive response that can be raised by DC sub- mational flexibility. Variability in CD1 conformations types. Langerhans’ cells (LCs), for example, do not express may therefore increase the antigen-presentation repertoire TLR4 and TLR5, whereas dermal interstitial DCs do express presented to CD1-restricted T-cell clones. TLR4 and TLR5.16 There is, furthermore, integration of sig- T-cell stimulation requires instructive signals that sup- nals downstream of PRRs: the simultaneous ligation of plement signals incited by triggering of the TCR. DCs in TLRs 3, 4 and 8 yields a 20–50-fold increase in interleukin particular are proficient at T-cell stimulation to mount (IL)-12 p70 production compared with the single ligation the adaptive immune responses most appropriate for the of either TLR;17,18 and TLR4 is located at the cell surface, pathogen at hand. DCs can rapidly and effectively form whereas TLRs 3 and 8 are found intracellularly, in endoso- peptide–MHC complexes or lipid–CD1 complexes derived mal compartments, thereby illuminating the fact that signal from encountered pathogens, and rapidly up-regulate the integration occurs distal from TLR cytosolic domains. Use surface expression of costimulatory molecules and chemo- of divergent sets of adaptor molecules for signal transduc- kine receptors.14 The possession of an elaborate endosomal tion (i.e. TIRAP-MyD88 and TRAM-TRIF) can direct the pathway, where antigens are degraded and loaded onto TLR-induced production of selective pro-inflammatory MHC or CD1, is likely to contribute to the success of cytokines.19 Cytosolic triggering of PRRs, through ligation DCs in stimulating antigen-specific T-cell responses. For- of NOD-like receptors, can, moreover, activate a caspase-1- eign-derived antigens are most readily acquired at barrier activating multiprotein complex called inflammasome.20 surfaces with the outside environment; only when patho- NACHT, LRR, and pyrin domain-containing proteins gens succeed at breaching the physical and chemical bar- (NALPs), which constitute the largest subfamily of the riers of skin and mucosa are they exposed to cells of the NOD-like receptors, process pro-inflammatory caspases immune system. It is becoming increasingly clear that and the cytokines IL-1b and IL-18 into their active forms.21 DCs form a network of cell types that have specialized If combined triggering of PRRs potentiates DC activation, characteristics: DCs found in barrier tissues acquire what is the effect of the simultaneous ligation of multiple mobility when pathogen-recognition receptors exposed on TLRs on the antigen processing and endosomal transport their plasma membrane are triggered, whereas other DC of peptide–MHC or lipid–CD1 complexes? subtypes found in secondary lymphoid tissues (i.e. The loading of Class II MHC and of CD1d with anti- murine CD8a+ DCs) do not have significant migratory genic cargo occurs in specializations of late endosomal capacities but are instead optimized for antigen cross-pre- and lysosomal compartments.22 Endosomal tubulation is sentation.15 DCs also have a potent ability to process and an early measure of DC maturation and is thought to present antigenic lipids in association with CD1. Trigger- facilitate the transport of peptide-loaded Class II MHC 164 Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170
  • 3. Regulated presentation of endosome-derived antigens by myeloid dendritic cells complexes to the cell surface.23,24 In maturing DCs, CD1 Dendritic cell molecules are not mobilized to endosomal tubules and do Immature Mature not exhibit rapid surface display as seen for Class II MHC.25,26 The loading of Class I MHC for cross-presenta- tion can occur in early endosomes/phagosomes5,27 as well as in the endoplasmic reticulum28 and perhaps also in a hybrid form of these two combined.29,30 The assortment of Class I MHC molecules that are found in early endoso- mal compartments are recycling Class I MHC molecules from the surface.31,32 The origin of Class I MHC complexes that localize to the cell surface during DC Endosomal maturation, however, is new synthesis rather than transfer compartments of existing Class I MHC present in endosomal/lysosomal compartments33 and is therefore not expected to be strongly represented in endosomal tubulations. The DC Golgi system Class I MHC maturation-associated disposition of Class I MHC, Class mCD1d Class II MHC Endoplasmic chains II MHC and mouse CD1d complexes in various subcellu- reticulum lar compartments is summarized in Fig. 1. Antigen degra- dation in endosomal compartments is also regulated in Class I MHC heavy chain with β2m and peptide Endosome with transporter associated with DCs:34,35 DCs exhibit less lysosomal proteolysis than antigen processing (TAP) macrophages.36–38 In DCs, a low level production of mCD1d heavy chain with β2m and glycolipid Putative mCD1d chaperone molecule reactive oxygen species produced by NADPH oxidase Class II MHC α and β chain with partially Microbe consumes protons in the phagosomal lumen, supporting a cleaved invariant chain near-neutral pH environment and favouring peptide H2-DM Antigenic glycolipid and peptide retention for presentation to T cells. This delay in antigen degradation apparently promotes antigen cross-presenta- Figure 1. Intracellular distribution and trafficking of Class I major tion via Class I MHC.38 Control of antigen degradation histocompatibility complex (MHC), Class II MHC and mouse CD1d may additionally involve regulation in spatially confined (mCD1d) in maturing dendritic cells. Complexes are assembled in the endoplasmic reticulum (ER). To allow them to fold into functional antigen-containing compartments rather than regulation complexes in the ER, chaperone molecules are co-assembled: antigenic at a cellular level, for example by local ligation of PRRs.39 peptide–Class I MHC; invariant chain–Class II MHC; and endogenous TLRs can be triggered inside endosomal compartments by lipid–CD1d (i.e. phosphatidylinositol and glycosyl-phosphatidylinosi- phagocytosed microbes.40 Triggering of PRRs can induce tol).96,97 After arrival at the cell surface by routing through the maturation of selective PAMP-containing phagosomes and secretory pathway, Class I MHC display and CD1d molecules recycle thereby promotes the generation of peptide–MHC through early endocytic compartments, from where CD1d molecules complexes in PAMP-containing phagosomes.41 PRR trig- are sorted to late endocytic/lysosomal compartments for exchange of gering promotes CD1d-mediated lipid presentation.42–44 It ER-derived lipid for antigenic lipid cargo. Most nascent invariant is not clear, however, whether NADPH oxidase activity chain–Class II MHC complexes arrive in the endosomal pathway modulates the generation of lipid–CD1 complexes in DCs. directly from the Golgi system for acquisition of antigenic peptide. Chaperone proteins can facilitate antigen loading in the ER (Class I loading complex for Class I MHC98 and some processes of CD1d Pattern recognition receptors as modulators of assembly,99 and lipid transfer proteins for lipid loading)100 and in endosomal composition the endosomal pathway (H2-DM for Class II MHC101,102 and lipid transfer proteins for mCD1d).92,95,103 Maturation of DCs rearranges The ligation of TLRs induces the transcription of genes intracellular trafficking to promote the presentation of newly acquired that collectively facilitate the differentiation process in antigen from ER or endosomes at the cell surface, for inspection by DCs called maturation. The integration of TLR-induced appropriately restricted T cells. Arrow thickness represents the relative signals makes use of adaptor proteins, the most studied of rate of translocation of Class I MHC, Class II MHC and mCD1d which is MyD88, which is involved in signal transduction complexes. b2m, beta-2-microglobulin. downstream of TLRs 1, 2, 4, 5, 6, 7 and 9 in mice.45 MyD88-deficient APCs exhibit deficiencies in antigen cross-presentation and are defective in eliciting functional was suggested that the cross-presentation of soluble anti- cytotoxic T lymphocytes (CTL) in vivo.46 Cross-presenta- gens which contain PAMPs is especially dependent on the tion of phagosomal antigens by myeloid DCs requires pro- loading of Class I MHC in early endosomes/phagosomes: cessing by the proteasome in most experimental systems, antigen cross-presentation required TLR4/MyD88-medi- thereby inferring the necessity to transfer protein frag- ated signals for phagosomal recruitment of transporter ments from the endosomal pathway into the cytosol.47 It associated with antigen processing (TAP) heterodimers Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170 165
  • 4. M. Boes et al. (TAP1/2).5 Triggering of TLR4 via treatment with lipo- excluded from cross-presentation.63 Some receptors are polysaccharide (LPS) also stimulates, in DCs, the rear- more effective than others at targeting of antigen for rangement of endosomal compartments to exhibit tubular cross-presentation: Gram-negative bacteria (whose structures.23,24,48,49 Class I MHC molecules are also con- uptake by DCs is facilitated by binding to complement centrated in multivesicular bodies (MVB) of the endoso- receptor 3) are fully degraded, whereas peptide antigen mal pathway,50 which represent the structures from which expressed by bacteria internalized via binding to receptors tubular endosomes are formed.48 MyD88-deficient DCs do to the Fc portion of immunoglobulins (Fc-receptors) are not form tubular endosomes when triggered with LPS, yet effectively cross-presented.63 Recruitment of the Rab27a do form tubular endosomes when triggered with small GTPase to phagosomal membranes is involved in Cryptococcus neoformans.51 C. neoformans can ligate TLR2 this antigen cross-presentation process in DCs, which also in addition to TLR4, whose signaling cascades both includes NADPH oxidase recruitment.64 CD1-mediated involve MyD88 as well as TIRAP and TRIF, respectively.45 antigen presentation of exogenous antigen also benefits The ligation of TLR3 (which is expressed on the from receptor-mediated uptake, for example via the endosomal membranes of CD8a+ DCs) with double- C-type lectins Langerin and DC-SIGN, mannose receptor stranded RNA (dsRNA) present in the cell-associated and low-density lipoprotein receptors (LDL-R),65–68 form of phagocytosed virus-infected cells promotes cross- although details that link receptor-mediated uptake with priming and induction of antigen-specific CTLs.52 endosomal processing of lipid antigens are scarce.68 Co-ligation of multiple TLRs also potentiates CTL Uptake of apoptotic blebs (for example through binding responses in vivo.53 What is known about endosomal to b3 integrins or to CD14) can also introduce mechanisms that link TLR ligation with endosomal antigenic cargo to Class I MHC and CD1 molecules remodeling and possibly with antigen presentation via into uninfected bystander DCs, as was shown using Class I MHC or CD1? apoptotic macrophages that harbored Salmonella typhimu- rium or Mycobacterium tuberculosis.69,70 Ceramides, lipids that are composed of a sphingosine Endosomal sorting of Class I MHC and CD1 for and fatty acid chain, are crucial for sorting lipids and antigen acquisition proteins into intravesicular membranes of exosomes and DC maturation induced by TLR ligation stimulates new MVBs.71 The endosomal-sorting mechanisms for peptide synthesis of Class I MHC molecules and induces antigen loading of Class II MHC in MVBs are relatively well loading of small stores of phagosomal Class I MHC.5 A established.22 In unstimulated cells, both glycosphingo- fraction of the cellular content of Class I MHC is found lipid (GSL) ligands and CD1d are also found in in late endosomal compartments.50,54 Surface display of MVBs.72 Microbial infection of susceptible hosts, how- endosomal Class I MHC via exosome release, however, is ever, rearranges the CD1-mediated antigen-presentation down-regulated when DCs undergo maturation.55 Upon pathway to accommodate the stimulatory effects of exposure to inflammatory stimuli, Class II MHC mole- CD1-restricted NKT-cell responses.43,44 Microbial infec- cules acquire antigen in phagosomes/lysosomes, then tions yield presentation of acquired lipids or mobilized accumulate on the plasma membrane to display peptides self-derived lipids by APCs. Infection with Ehrlichia to CD4 T cells as part of DC maturation.56,57 Matura- muris and Sphingomonas capsulata, for example, causes tion-induced relocation of antigen-loaded Class I MHC CD1d-mediated NKT-cell activation primarily through and CD1 from the endosomal pathway to the cell surface direct recognition of microbial lipids.43 By contrast, is relatively modest when compared with the maturation- S. typhimurium infection causes stimulation of autoreac- induced relocation of antigen-loaded Class II MHC. Stim- tive NKT cells through a combination of endogenous ulation of antigen-specific CD8 T-cell clones to acquire GSL presentation via mouse CD1d and PRR-induced cytotoxic killing of target cells requires as few as three IL-12 production.43,44 The outer membranes of M. tuber- peptide–Class I MHC complexes,58 which is one to two culosis bacilli contain lipid ligands for CD1-mediated ¨ orders of magnitude less than required to stimulate naıve presentation and lipid adjuvants that induce CD1 anti- CD4 T cells.59,60 Unlike Class II MHC, the trafficking of gen-processing pathways through TLRs.26,42,70 Finally, CD1 molecules and the presentation of lipid antigens is infection of host cells can increase the synthesis of comparable between both immature and mature endogenous GSL and stimulate GSL-specific T cells in a DCs.25,61,62 TLR-mediated signals stimulate specific anti- CD1- and TCR-dependent manner, as shown using gen loading of Class I MHC and CD1 complexes in the Escherichia coli, Bacilus subtilis, Staphylococcus aureus and endosomal pathway, with less consequence to the ongoing Mycobacterium bovis-bacille Calmette Guerin (BCG).73 ´ surface-directed traffic. Induction of invariant NKT (iNKT)-cell responses upon Receptor-mediated uptake effectively introduces antigen viral infection in mice involves TLR9 signaling and con- into the cross-presentation pathway, whereas antigen sequent production of IL-12, while the necessity of internalized by way of fluid-phase uptake is mostly CD1d-mediated presentation may not be absolute.74 166 Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170
  • 5. Regulated presentation of endosome-derived antigens by myeloid dendritic cells Yersinia enterocolitica and Klebsiella pneumoniae).83–86 Virus-infection interference with endosomal Bacterial products can inhibit the cross-presentation of antigen presentation mediated by CD1 and Class particulate antigen via Class I MHC in a manner that I MHC requires PAMP binding to TLRs and MyD88. Inhibition DC activation accomplished through TLR ligation, for of cross-presentation through this route occurs through example, is pivotal for effective antigen cross-presentation interference with phagosome maturation and antigen pro- as discussed above. Infection with certain large viruses teolysis, as shown for the M. tuberculosis 19 000 MW that harbor ligands for TLRs can, however, also interfere lipoprotein, CpG DNA and LPS.87 Moreover, cell wall- with antigen cross-presentation. The b-herpes virus, associated alpha-glucan from M. tuberculosis can induce mouse cytomegalovirus (MCMV), contains immune- monocytes to differentiate into DCs that lack CD1 expres- evasion genes that may affect some aspects of antigen sion, fail to up-regulate CD80 and produce IL10, render- cross-presentation as it does for the direct pathway of ing them unable to prime effector T cells or present lipid Class I MHC presentation.75 Herpes simplex virus-1 antigens to CD1-restricted T cells.88 (HSV-1) and herpes simplex virus-2 (HSV-2), for exam- ple, express a protein called ICP47, which blocks peptide Interference with CD1-mediated antigen loading transport via the TAP1/2 transporter.76 Human cytomega- in inherited disease lovirus (HCMV) contains another TAP1/2 inhibitor, US6.77 The use of a US6-transferrin chimeric molecule Class II MHC molecules acquire their peptide cargo in was used to infer the role of TAP1/2 in transporting anti- specialized compartments of the late endosomal pathway, genic peptide from the cytosol into phagosomes in the including MVBs, where the peptide-exchange factor HLA- process of cross-presentation of phagosomal antigen.5 DM (H2-DM in mice) localizes.89,90 In analogy, late Mouse DCs that are infected with MCMV activate endosomal compartments are enriched for lipid-binding CD1d-restricted iNKT cells in co-culture systems and proteins, some of which may function in the exchange of in vivo.74 Human DCs that are infected with the human endoplasmic reticulum-derived lipids for antigenic lipids cytomegalovirus (HCMV) or HSV-1 also up-regulate onto CD1 molecules (i.e. saposins A, B, C and D) and antigen presentation via CD1d, which is the only group 2 Niemann-pick type C2 protein.91,92 Saposins function in CD1 molecule.78 However, HCMV infection of human a non-enzymatic manner, the exact mechanisms of which DCs inhibits NKT-cell activation by CD1a, b and c (the are not yet fully understood. Lack of saposin function so-called group 1 CD1 molecules), as characterized by causes lipid storage diseases, such as a form of Krabbe accumulation of CD1 in endosomal/lysosomal compart- disease, which develops as a result of saposin A defi- ments and by the direct measurement of CD1b-restricted ciency.93 Other known sphingolipid activator proteins are NKT-cell activation presented by infected DCs.79 One GM2 and saposins B, C and D, which are all post-transla- possible explanation for differential responses to viral tional products of the prosaposin gene.94 Mice that are insult of group 1 and group 2 CD1 molecules in humans deficient in prosaposin lack Va14 iNKT cells, yet have a lies in regulatory elements in the 50 untranslated region, normal ability to present peptide–Class II MHC com- which is conserved for group 1 CD1 and distinct for plexes.95 Deficiencies that involve only proteins for anti- CD1d.80 At high multiplicity of infection (MOI) of HSV- gen cross-presentation, while excluding those concerned 1 (MOI of 5–10), however, CD1d-mediated presentation with the direct pathway of Class I MHC-mediated presen- is also blocked, possibly through inhibition of CD1d tation, are to our knowledge yet to be described. Candi- recycling to the cell surface.72,81 dates should be found amongst proteins involved with the phagosomal milieu, especially those related to antigen processing, peptide transport past the phagosomal mem- Bacterial infection interference with endosomal brane and assembly into peptide–Class I MHC complexes. antigen presentation mediated by CD1 and Class I MHC Concluding remarks Intracellular bacteria, including mycobacteria, also have escape mechanisms for antigen presentation mediated by The mechanisms that support the endosomal processing Class I MHC or CD1. Bacteria can evade Class II MHC machinery in professional APCs for presentation of exo- antigen presentation by infected cells through alteration genous antigen via Class I MHC or CD1 complexes are of phagosome–lysosome fusion or biosynthesis, intracellu- currently being uncovered. It is our hope that new acces- lar trafficking and surface expression of Class II MHC, as sory proteins and pivotal mechanisms are found that recently reviewed.82 Peptide–Class I MHC complex pre- facilitate selectively, in the endosomal microenviroment, sentation can be obstructed through interference with the the sorting of antigen, proteolysis and loading of Class I surface expression of Class I MHC (e.g. as in infections MHC and CD1. Elucidation of the endosomal processes with Chlamydia pneumoniae, Salmonella enteritidis, that underlie the display of antigen-loaded Class I MHC Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170 167
  • 6. M. Boes et al. and CD1 complexes should yield insights for future thera- 18 Gautier G, Humbert M, Deauvieau F et al. A type I interferon pies aimed at potentiation of cytotoxic T-cell responses to autocrine-paracrine loop is involved in Toll-like receptor- phagocytosed antigens of viral or microbial origin. induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201:1435–46. 19 Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. Disclosures TRAM couples endocytosis of Toll-like receptor 4 to the induc- tion of interferon-beta. Nat Immun 2008; 9:361–8. All authors declare no conflicts of interest. 20 Petrilli V, Dostert C, Muruve DA, Tschopp J. The inflamma- some: a danger sensing complex triggering innate immunity. References Curr Opin Immunol 2007; 19:615–22. 21 Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, 1 Ueno H, Klechevsky E, Morita R et al. Dendritic cell subsets in Tschopp J. NALP3 forms an IL-1beta-processing inflammasome health and disease. Immunol Rev 2007; 219:118–42. with increased activity in Muckle–Wells autoinflammatory disor- 2 Picker LJ, Siegelman MH. in Paul W.E. Fundamental Immunology, der. Immunity 2004; 20:319–25. 3rd edn. Philadelphia, PA: Lippinscott Williams & Wilkins, 1993. 22 Wolf PR, Ploegh HL. How MHC class II molecules acquire pep- 3 Bendelac A. Positive selection of mouse NK1 + T cells by tide cargo: biosynthesis and trafficking through the endocytic CD1-expressing cortical thymocytes. J Exp Med 1995; 182: pathway. Annu Rev Cell Dev Biol 1995; 11:267–306. 2091–6. 23 Boes M, Cerny J, Massol R, Op den Brouw M, Kirchhausen T, 4 Sprengers D, Sille FC, Derkow K, Besra GS, Janssen HL, Schott Chen J, Ploegh HL. T-cell engagement of dendritic cells rapidly E, Boes M. Critical role for CD1d-restricted invariant NKT cells rearranges MHC class II transport. Nature 2002; 418:983–8. in stimulating intrahepatic CD8 T-cell responses to liver antigen. 24 Chow A, Toomre D, Garrett W, Mellman I. Dendritic cell matu- Gastroenterology 2008; 134:2132–43. ration triggers retrograde MHC class II transport from lyso- 5 Burgdorf S, Scholz C, Kautz A, Tampe R, Kurts C. Spatial and somes to the plasma membrane. Nature 2002; 418:988–94. mechanistic separation of cross-presentation and endogenous 25 van der Wel NN, Sugita M, Fluitsma DM, Cao X, Schreibelt G, antigen presentation. Nat Immun 2008; 9:558–66. Brenner MB, Peters PJ. CD1 and major histocompatibility com- 6 Sugita M, Grant EP, van Donselaar E, Hsu VW, Rogers RA, plex II molecules follow a different course during dendritic cell Peters PJ, Brenner MB. Separate pathways for antigen presenta- maturation. Mol Biol Cell 2003; 14:3378–88. tion by CD1 molecules. Immunity 1999; 11:743–52. 26 Skold M, Xiong X, Illarionov PA, Besra GS, Behar SM. Interplay 7 Bradbury A, Calabi F, Milstein C. Expression of CD1 in the of cytokines and microbial signals in regulation of CD1d expres- mouse thymus. Eur J Immunol 1990; 20:1831–6. sion and NKT cell activation. J Immunol 2005; 175:3584–93. 8 de la Salle H, Mariotti S, Angenieux C et al. Assistance of 27 Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Early phago- microbial glycolipid antigen processing by CD1e. Science (New somes in dendritic cells form a cellular compartment sufficient York, NY) 2005; 310:1321–4. for cross presentation of exogenous antigens. Proc Natl Acad Sci 9 Bendelac A, Savage PB, Teyton L. The biology of NKT cells. USA 2003; 100:12889–94. Annu Rev Immunol 2007; 25:297–336. 28 Ackerman AL, Kyritsis C, Tampe R, Cresswell P. Access of solu- 10 Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L. Crys- ble antigens to the endoplasmic reticulum can explain cross- tal structures of mouse CD1d-iGb3 complex and its cognate presentation by dendritic cells. Nat Immun 2005; 6:107–13. Valpha14 T cell receptor suggest a model for dual recognition of 29 Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, Van Endert foreign and self glycolipids. J Mol Biol 2008; 377:1104–16. P, Amigorena S. ER-phagosome fusion defines an MHC class I 11 Bouvier M, Wiley DC. Importance of peptide amino and car- cross-presentation compartment in dendritic cells. Nature 2003; boxyl termini to the stability of MHC class I molecules. Science 425:397–402. (New York, NY) 1994; 265:398–402. 30 Houde M, Bertholet S, Gagnon E et al. Phagosomes are competent 12 Rammensee HG. Chemistry of peptides associated with MHC organelles for antigen cross-presentation. Nature 2003; 425:402–6. class I and class II molecules. Curr Opin Immunol 1995; 7:85–96. 31 Vega MA, Strominger JL. Constitutive endocytosis of HLA class 13 Moody DB, Reinhold BB, Guy MR et al. Structural requirements I antigens requires a specific portion of the intracytoplasmic tail for glycolipid antigen recognition by CD1b-restricted T cells. that shares structural features with other endocytosed molecules. Science (New York, NY) 1997; 278:283–6. Proc Natl Acad Sci USA 1989; 86:2688–92. 14 Banchereau J, Steinman RM. Dendritic cells and the control of 32 Reid PA, Watts C. Cycling of cell-surface MHC glycoproteins immunity. Nature 1998; 392:245–52. through primaquine-sensitive intracellular compartments. Nature 15 Heath WR, Belz GT, Behrens GM et al. Cross-presentation, den- 1990; 346:655–7. dritic cell subsets, and the generation of immunity to cellular 33 Delamarre L, Holcombe H, Mellman I. Presentation of exoge- antigens. Immunol Rev 2004; 199:9–26. nous antigens on major histocompatibility complex (MHC) class 16 van der Aar AM, Sylva-Steenland RM, Bos JD, Kapsenberg ML, I and MHC class II molecules is differentially regulated during de Jong EC, Teunissen MB. Loss of TLR2, TLR4, and TLR5 on dendritic cell maturation. J Exp Med 2003; 198:111–22. Langerhans cells abolishes bacterial recognition. J Immunol 2007; 34 Blander JM, Medzhitov R. On regulation of phagosome matura- 178:1986–90. tion and antigen presentation. Nat Immun 2006; 7:1029–35. 17 Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. 35 Savina A, Amigorena S. Phagocytosis and antigen presentation Selected Toll-like receptor agonist combinations synergistically in dendritic cells. Immunol Rev 2007; 219:143–56. trigger a T helper type 1-polarizing program in dendritic cells. 36 Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Nat Immun 2005; 6:769–76. Differential lysosomal proteolysis in antigen-presenting cells 168 Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170
  • 7. Regulated presentation of endosome-derived antigens by myeloid dendritic cells determines antigen fate. Science (New York, NY) 2005; 307: 55 Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi- 1630–4. Castagnoli P, Raposo G, Amigorena S. Molecular characteriza- 37 Lennon-Dumenil AM, Bakker AH, Maehr R, Fiebiger E, Over- tion of dendritic cell-derived exosomes. Selective accumulation kleeft HS, Rosemblatt M, Ploegh HL, Lagaudriere-Gesbert C. of the heat shock protein hsc73. J Cell Biol 1999; 147:599–610. Analysis of protease activity in live antigen-presenting cells 56 Inaba K, Turley S, Iyoda T et al. The formation of immunogenic shows regulation of the phagosomal proteolytic contents during major histocompatibility complex class II-peptide ligands in dendritic cell activation. J Exp Med 2002; 196:529–40. lysosomal compartments of dendritic cells is regulated by 38 Savina A, Jancic C, Hugues S et al. NOX2 controls phagosomal inflammatory stimuli. J Exp Med 2000; 191:927–36. pH to regulate antigen processing during crosspresentation by 57 Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflam- dendritic cells. Cell 2006; 126:205–18. matory stimuli induce accumulation of MHC class II complexes 39 Kim SH, Visser A, Cruijsen C, van der Velden AW, Boes M. on dendritic cells. Nature 1997; 388:782–7. Recruitment of Rab27a to phagosomes controls microbial anti- 58 Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing gen cross-presentation by dendritic cells. Infect Immun 2008; does not require the formation of a stable mature immunologi- 76:5373–80. cal synapse. Nat Immun 2004; 5:524–30. 40 Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 59 Harding CV, Unanue ER. Quantitation of antigen-presenting cell delivers nucleotide-sensing toll-like receptors to endolysosomes. MHC class II/peptide complexes necessary for T-cell stimulation. Nature 2008; 452:234–8. Nature 1990; 346:574–6. 41 Blander JM, Medzhitov R. Regulation of phagosome maturation 60 Demotz S, Grey HM, Sette A. The minimal number of class II by signals from toll-like receptors. Science (New York, NY) 2004; MHC-antigen complexes needed for T cell activation. Science 304:1014–18. (New York, NY) 1990; 249:1028–30. 42 Roura-Mir C, Wang L, Cheng TY et al. Mycobacterium tuber- 61 Cao X, Sugita M, Van Der Wel N, Lai J, Rogers RA, Peters PJ, culosis regulates CD1 antigen presentation pathways through Brenner MB. CD1 molecules efficiently present antigen in TLR-2. J Immunol 2005; 175:1758–66. immature dendritic cells and traffic independently of MHC class 43 Mattner J, Debord KL, Ismail N et al. Exogenous and endoge- II during dendritic cell maturation. J Immunol 2002; 169: nous glycolipid antigens activate NKT cells during microbial 4770–7. infections. Nature 2005; 434:525–9. 62 Hava DL, van der Wel N, Cohen N et al. Evasion of peptide, 44 Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism but not lipid antigen presentation, through pathogen-induced of CD1d-restricted natural killer T cell activation during micro- dendritic cell maturation. Proc Natl Acad Sci USA 2008; bial infection. Nat Immun 2003; 4:1230–7. 105:11281–6. 45 Kumagai Y, Takeuchi O, Akira S. Pathogen recognition by 63 Amigorena S, Bonnerot C. Fc receptors for IgG and antigen pre- innate receptors. J Infect Chemother 2008; 14:86–92. sentation on MHC class I and class II molecules. Semin Immu- 46 Palliser D, Ploegh H, Boes M. Myeloid differentiation factor 88 is nol 1999; 11:385–90. required for cross-priming in vivo. J Immunol 2004; 172:3415–21. 64 Jancic C, Savina A, Wasmeier C et al. Rab27a regulates phagoso- 47 Lin ML, Zhan Y, Villadangos JA, Lew AM. The cell biology of mal pH and NADPH oxidase recruitment to dendritic cell cross-presentation and the role of dendritic cell subsets. Immu- phagosomes. Nat Cell Biol 2007; 9:367–78. nol Cell Biol 2008; 86:353–62. 65 Hunger RE, Sieling PA, Ochoa MT et al. Langerhans cells utilize 48 Kleijmeer M, Ramm G, Schuurhuis D et al. Reorganization of CD1a and langerin to efficiently present nonpeptide antigens to multivesicular bodies regulates MHC class II antigen presenta- T cells. J Clin Invest 2004; 113:701–8. tion by dendritic cells. J Cell Biol 2001; 155:53–63. 66 Tailleux L, Schwartz O, Herrmann JL et al. DC-SIGN is the 49 Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T, major Mycobacterium tuberculosis receptor on human dendritic Ploegh H. T cells induce extended class II MHC compartments cells. J Exp Med 2003; 197:121–7. in dendritic cells in a Toll-like receptor-dependent manner. 67 Prigozy TI, Sieling PA, Clemens D et al. The mannose receptor J Immunol 2003; 171:4081–8. delivers lipoglycan antigens to endosomes for presentation to T 50 Kleijmeer MJ, Escola JM, UytdeHaag FG et al. Antigen loading cells by CD1b molecules. Immunity 1997; 6:187–97. of MHC class I molecules in the endocytic tract. Traffic 2001; 68 van den Elzen P, Garg S, Leon L et al. Apolipoprotein-medi- 2:124–37. ated pathways of lipid antigen presentation. Nature 2005; 51 Vyas JM, Kim YM, Artavanis-Tsakonas K, Love JC, Van der 437:906–10. Veen AG, Ploegh HL. Tubulation of class II MHC compart- 69 Yrlid U, Wick MJ. Salmonella-induced apoptosis of infected ments is microtubule dependent and involves multiple endo- macrophages results in presentation of a bacteria-encoded anti- lysosomal membrane proteins in primary dendritic cells. gen after uptake by bystander dendritic cells. J Exp Med 2000; J Immunol 2007; 178:7199–210. 191:613–24. 52 Schulz O, Diebold SS, Chen M et al. Toll-like receptor 3 pro- 70 Schaible UE, Winau F, Sieling PA et al. Apoptosis facilitates motes cross-priming to virus-infected cells. Nature 2005; antigen presentation to T lymphocytes through MHC-I and CD1 433:887–92. in tuberculosis. Nat Med 2003; 9:1039–46. 53 Warger T, Osterloh P, Rechtsteiner G et al. Synergistic activation 71 Trajkovic K, Hsu C, Chiantia S et al. Ceramide triggers budding of dendritic cells by combined Toll-like receptor ligation induces of exosome vesicles into multivesicular endosomes. Science (New superior CTL responses in vivo. Blood 2006; 108:544–50. York, NY) 2008; 319:1244–7. 54 Gromme M, Uytdehaag FG, Janssen H et al. Recycling MHC 72 Yuan W, Dasgupta A, Cresswell P. Herpes simplex virus evades class I molecules and endosomal peptide loading. Proc Natl Acad natural killer T cell recognition by suppressing CD1d recycling. Sci U S A 1999; 96:10326–31. Nat Immun 2006; 7:835–42. Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170 169
  • 8. M. Boes et al. 73 De Libero G, Moran AP, Gober HJ et al. Bacterial infections is instrumental for Mycobacterium tuberculosis to block CD1 promote T cell recognition of self-glycolipids. Immunity 2005; molecule expression and disable the function of dendritic cell 22:763–72. derived from infected monocyte. Cell Microbiol 2007; 9:2081–92. 74 Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, Kro- 89 Sanderson F, Kleijmeer MJ, Kelly A, Verwoerd D, Tulp A, Neef- nenberg M. Cutting edge: the mechanism of invariant NKT cell jes JJ, Geuze HJ, Trowsdale J. Accumulation of HLA-DM, a reg- responses to viral danger signals. J Immunol 2008; 181:4452–6. ulator of antigen presentation, in MHC class II compartments. 75 Yewdell JW, Hill AB. Viral interference with antigen presenta- Science (New York, NY) 1994; 266:1566–9. tion. Nat Immun 2002; 3:1019–25. 90 Kleijmeer MJ, Raposo G, Geuze HJ. Characterization of MHC 76 Galocha B, Hill A, Barnett BC et al. The active site of ICP47, a class II compartments by immunoelectron microscopy. Methods herpes simplex virus-encoded inhibitor of the major histocom- 1996; 10:191–207. patibility complex (MHC)-encoded peptide transporter associ- 91 Locatelli-Hoops S, Remmel N, Klingenstein R et al. Saposin A ated with antigen processing (TAP), maps to the NH2-terminal mobilizes lipids from low cholesterol and high bis(monoa- 35 residues. J Exp Med 1997; 185:1565–72. cylglycerol)phosphate-containing membranes: patient variant 77 Hengel H, Flohr T, Hammerling GJ, Koszinowski UH, Mom- Saposin A lacks lipid extraction capacity. J Biol Chem 2006; burg F. Human cytomegalovirus inhibits peptide translocation 281:32451–60. into the endoplasmic reticulum for MHC class I assembly. J Gen 92 Schrantz N, Sagiv Y, Liu Y, Savage PB, Bendelac A, Teyton L. Virol 1996; 9:2287–96. The Niemann-Pick type C2 protein loads isoglobotrihexosylcera- 78 Raftery MJ, Winau F, Giese T, Kaufmann SH, Schaible UE, mide onto CD1d molecules and contributes to the thymic selec- Schonrich G. Viral danger signals control CD1d de novo synthe- tion of NKT cells. J Exp Med 2007; 204:841–52. sis and NKT cell activation. Eur J Immunol 2008; 38:668–79. 93 Spiegel R, Bach G, Sury V et al. A mutation in the saposin A 79 Raftery MJ, Hitzler M, Winau F, Giese T, Plachter B, Kaufmann coding region of the prosaposin gene in an infant presenting as SH, Schonrich G. Inhibition of CD1 antigen presentation by Krabbe disease: first report of saposin A deficiency in humans. human cytomegalovirus. J Virol 2008; 82:4308–19. Mol Genet Metab 2005; 84:160–6. 80 Balk SP, Bleicher PA, Terhorst C. Isolation and characterization 94 Vielhaber G, Hurwitz R, Sandhoff K. Biosynthesis, processing, of a cDNA and gene coding for a fourth CD1 molecule. Proc and targeting of sphingolipid activator protein (SAP)precursor Natl Acad Sci USA 1989; 86:252–6. in cultured human fibroblasts. Mannose 6-phosphate receptor- 81 Raftery MJ, Winau F, Kaufmann SH, Schaible UE, Schonrich G. independent endocytosis of SAP precursor. J Biol Chem 1996; CD1 antigen presentation by human dendritic cells as a target 271:32438–46. for herpes simplex virus immune evasion. J Immunol 2006; 95 Zhou D, Cantu C 3rd, Sagiv Y et al. Editing of CD1d-bound 177:6207–14. lipid antigens by endosomal lipid transfer proteins. Science (New 82 Harding CV, Ramachandra L, Wick MJ. Interaction of bacteria York, NY) 2004; 303:523–7. with antigen presenting cells: influences on antigen presentation 96 Joyce S, Woods AS, Yewdell JW et al. Natural ligand of mouse and antibacterial immunity. Curr Opin Immunol 2003; 15:112– CD1d1: cellular glycosylphosphatidylinositol. Science (New York, 19. NY) 1998; 279:1541–4. 83 Huang F, Yamaguchi A, Tsuchiya N et al. Induction of alterna- 97 Park JJ, Kang SJ, De Silva AD, Stanic AK, Casorati G, Hachey tive splicing of HLA-B27 by bacterial invasion. Arthritis Rheum DL, Cresswell P, Joyce S. Lipid-protein interactions: biosynthetic 1997; 40:694–703. assembly of CD1 with lipids in the endoplasmic reticulum is 84 Kirveskari J, He Q, Leirisalo-Repo M, Maki-Ikola O, Wuorela evolutionarily conserved. Proc Natl Acad Sci USA 2004; M, Putto-Laurila A, Granfors K. Enterobacterial infection modu- 101:1022–6. lates major histocompatibility complex class I expression on 98 Cresswell P, Bangia N, Dick T, Diedrich G. The nature of the mononuclear cells. Immunology 1999; 97:420–8. MHC class I peptide loading complex. Immunol Rev 1999; 85 Wuorela M, Jalkanen S, Kirveskari J, Laitio P, Granfors K. Yer- 172:21–8. sinia enterocolitica serotype O:3 alters the expression of sero- 99 Kang SJ, Cresswell P. Calnexin, calreticulin, and ERp57 cooper- logic HLA-B27 epitopes on human monocytes. Infect Immun ate in disulfide bond formation in human CD1d heavy chain. 1997; 65:2060–6. J Biol Chem 2002; 277:44838–44. 86 Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcrip- 100 Brozovic S, Nagaishi T, Yoshida M et al. CD1d function is regu- tion factor RFX5 during the inhibition of both constitutive and lated by microsomal triglyceride transfer protein. Nat Med 2004; interferon gamma-inducible major histocompatibility complex 10:535–9. class I expression in chlamydia-infected cells. J Exp Med 2000; 101 Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mel- 191:1525–34. lins E, Zaller DM. Mediation by HLA-DM of dissociation of 87 Tobian AA, Potter NS, Ramachandra L, Pai RK, Convery M, peptides from HLA-DR. Nature 1995; 375:802–6. Boom WH, Harding CV. Alternate class I MHC antigen process- 102 Boes M, Cuvillier A, Ploegh H. Membrane specializations and ing is inhibited by Toll-like receptor signaling pathogen-associ- endosome maturation in dendritic cells and B cells. Trends Cell ated molecular patterns: Mycobacterium tuberculosis 19-kDa Biol 2004; 14:175–83. lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003; 103 Sagiv Y, Bai L, Wei DG, Agami R, Savage PB, Teyton L, Bende- 171:1413–22. lac A. A distal effect of microsomal triglyceride transfer protein 88 Gagliardi MC, Lemassu A, Teloni R, Mariotti S, Sargentini V, deficiency on the lysosomal recycling of CD1d. J Exp Med 2007; Pardini M, Daffe M, Nisini R. Cell wall-associated alpha-glucan 204:921–8. 170 Ó 2009 Blackwell Publishing Ltd, Immunology, 127, 163–170